FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Shahrokh Shariat

Research Profile

Disorders

Concepts & Ideas

Procedures

Chemicals & Drugs

Anatomy

Urothelium

Physiology

Disease Progression

Co-author Network

Publications

TOP 3
evanguelos xylinas; Luis Kluth; Shahrokh F Shariat
Re: Effect of Abiraterone Acetate and Prednisone Compared with Placebo and Prednisone on Pain Control and Skeletal-related Events in Patients with Metastatic Castration-resistant Prostate Cancer: Exploratory Analysis of Data from the COU-AA-301 Randomised Trial.
evanguelos xylinas; Joseph J Crivelli; Luis A Kluth; Vitaly Margulis; Malte Rieken; Christian Seitz; Shahrokh F Shariat
Impact of statin use on oncologic outcomes of patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.
Morgan Rouprêt; Richard Sylvester; Bas W G van Rhijn; Richard Zigeuner; Marko Babjuk; Andreas Böhle; Max Burger; Eva Compérat; Nigel Cowan; Eero Kaasinen; Joan Palou; Shahrokh F Shariat
European guidelines on upper tract urothelial carcinomas: 2013 update.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Shahrokh Shariat (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: evanguelos xylinas; Luis Kluth; Shahrokh F Shariat
Re: Effect of Abiraterone Acetate and Prednisone Compared with Placebo and Prednisone on Pain Control and Skeletal-related Events in Patients with Metastatic Castration-resistant Prostate Cancer: Exploratory Analysis of Data from the COU-AA-301 Randomised Trial.
European urology 2013;63(6):1132-3.
2013: evanguelos xylinas; Joseph J Crivelli; Luis A Kluth; Vitaly Margulis; Malte Rieken; Christian Seitz; Shahrokh F Shariat
Impact of statin use on oncologic outcomes of patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.
European urology 2013;63(6):1134-5.
2013: Morgan Rouprêt; Richard Sylvester; Bas W G van Rhijn; Richard Zigeuner; Marko Babjuk; Andreas Böhle; Max Burger; Eva Compérat; Nigel Cowan; Eero Kaasinen; Joan Palou; Shahrokh F Shariat
European guidelines on upper tract urothelial carcinomas: 2013 update.
European urology 2013;63(6):1059-71.
2013: Firas Abdollah; Alberto Briganti; Giorgio Gandaglia; Claudio Jeldres; Pierre I Karakiewicz; Francesco Montorsi; Niccolò Maria Passoni; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Rodolphe Thuret; Zhe Tian; Maxine Sun
Incidence, survival and mortality rates of stage-specific bladder cancer in United States: A trend analysis.
Cancer epidemiology 2013;37(3):219-25.
2013: Stéphane Larré; Yair Lotan; Edward M Messing; Shahrokh F Shariat; Mark S Soloway; Robert S Svatek; Alexandre R Zlotta; James W F Catto; Michael S Cookson; H Barton Grossman
Screening for bladder cancer: rationale, limitations, whom to target, and perspectives.
European urology 2013;63(6):1049-58.
2013: Quoc-Dien Trinh; Zhe Tian; Firas Abdollah; Marco Bianchi; Jens Hansen; Pierre I Karakiewicz; Francesco Montorsi; Paul Perrotte; Shahrokh F Shariat; Maxine Sun
In-hospital Mortality and Failure to Rescue After Cytoreductive Nephrectomy.
European urology 2013;63(6):1107-14.
2013: Michael Rink; Douglas S Scherr; Shahrokh F Shariat; Christopher G Wood; evanguelos xylinas; Marko Babjuk; Eugene K Cha; Felix K Chun; Behfar Ehdaie; Margit Fisch; Helena Furberg; Pierre I Karakiewicz; Yair Lotan; Vitaly Margulis; Kazumasa Matsumoto; Armin Pycha; Jay D Raman
Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy.
European urology 2013;63(6):1082-90.
2013: L A Kluth; M Rink; Shahrokh F Shariat; fianceeyi chun; Margit Fisch; P Dahm
[Use and interpretation of the number needed to treat in urological practice].
Der Urologe. Ausg. A 2013;52(5):682-5.
2013: Aditya Bagrodia; Karim Bensalah; Ithaar H Derweesh; Bishoy A Gayed; Payal Kapur; Franklin E Kuehhas; Yair Lotan; Jay D Raman; Arthur I Sagalowsky; Shahrokh F Shariat; Christopher G Wood; Vitaly Margulis
Comparative Analysis of Oncologic Outcomes of Partial Ureterectomy vs Radical Nephroureterectomy in Upper Tract Urothelial Carcinoma.
Urology 2013;81(5):972-8.
2013: evanguelos xylinas; Marc Zerbib; Marko Babjuk; Antonin Brisuda; Talia Faison; Yves Fradet; David A Green; Pierre I Karakiewicz; Luis A Kluth; Richard K Lee; Yair Lotan; Armin Pycha; Michael Rink; Brian D Robinson; Douglas S Scherr; Shahrokh F Shariat
Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy.
European journal of cancer (Oxford, England : 1990) 2013;49(8):1889-97.
2013: Malte Rieken; Shahrokh F Shariat
Renal cancer therapy: going forward by going backward?
European urology 2013;63(5):890-1.
2013: Vitaly Margulis; Yury Rapoport; Michael Rink; Shahrokh F Shariat; Daniel D Sjoberg; Pheroze Tamboli; Nizar M Tannir; E Jason Abel; Stephen Hembree Culp; Christopher G Wood
Development of accurate models for individualized prediction of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.
European urology 2013;63(5):947-52.
2013: Morgan Rouprêt; François Rozet; Thomas Seisen; Shahrokh F Shariat; Thomas J Walton; Christopher G Wood; evanguelos xylinas; David R Yates; Richard Zigeuner; Karim Bensalah; Christian Bolenz; Pierre Colin; Olivier Cussenot; Harun Fajkovic; Hans-Martin Fritsche; Vincent Hupertan; Pierre I Karakiewicz; Wassim Kassouf; Yair Lotan; Vitaly Margulis; Juan I Martinez-Salamanca; Francesco Montorsi; Giacomo Novara; Adil Ouzzane; Jay D Raman; Mesut Remzi
Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis.
The Journal of urology 2013;189(5):1662-9.
2013: James W F Catto; Shahrokh F Shariat
The changing face of renal cell carcinoma: the impact of systematic genetic sequencing on our understanding of this tumor's biology.
European urology 2013;63(5):855-7; discussion 857-8.
2013: Wassim Kassouf; Seth P Lerner; Yair Lotan; Giacomo Novara; Arthur I Sagalowsky; Mark P Schoenberg; Shahrokh F Shariat; Armen Aprikian; Patrick J Bastian; Colin P N Dinney; Vincenzo Ficarra; Yves Fradet; Hans Martin Fritsche; Jonathan I Izawa; Ashish M Kamat; Pierre I Karakiewicz; Robert S Svatek; Derya Tilki; Eila C Skinner
Critical analysis and validation of lymph node density as prognostic variable in urothelial carcinoma of bladder.
Urologic oncology 2013;31(4):480-6.
2013: Maxine Sun; Quoc-Dien Trinh; Malek Meskawi; Paul Perrotte; Shahrokh F Shariat; Firas Abdollah; Marco Bianchi; Jens Hansen; Pierre I Karakiewicz
An evidence-based guide to the selection of sequential therapies in metastatic renal cell carcinoma.
Therapeutic advances in urology 2013;5(2):121-8.
2013: M Rink; Shahrokh F Shariat; R Dahlem; Margit Fisch; L A Kluth; P Dahm
[Confidence intervals and p-values in urology : Interpretation and misinterpretation].
Der Urologe. Ausg. A 2013;52(4):546-8.
2013: Bobby B Najari; Michael Rink; Douglas S Scherr; Peter N Schlegel; Ridwan Shabsigh; Pierre I Karakiewicz; Philip S Li; Siegfried Meryn; Shahrokh F Shariat
Sex disparities in cancer mortality: the risks of being a man in the United States.
The Journal of urology 2013;189(4):1470-4.
2013: Sigrid V Carlsson; Daher C Chade; James Eastham; Samson W Fine; Niccolo Passoni; Peter T Scardino; Shahrokh F Shariat; Daniel D Sjoberg; Laura J Tafe; Karim Touijer
Pathological features of lymph node metastasis for predicting biochemical recurrence after radical prostatectomy for prostate cancer.
The Journal of urology 2013;189(4):1314-9.
2013: Jesse D Sammon; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Marco Bianchi; Khurshid R Ghani; Jim C Hu; Pierre I Karakiewicz; Mani Menon; James O Peabody; Paul Perrotte; Praful Ravi; Quoc-Dien Trinh
Robot-assisted versus open radical prostatectomy: the differential effect of regionalization, procedure volume and operative approach.
The Journal of urology 2013;189(4):1289-94.
2013: Rodolphe Thuret; Jean-Jacques Patard; Shahrokh F Shariat; Maxine Sun; Firas Abdollah; Lars Budaus; Jacques Guiter; François Iborra; Pierre I Karakiewicz
Competing-risks analysis in patients with T1 squamous cell carcinoma of the penis.
BJU international 2013;111(4 Pt B):E174-9.
2013: Firas Abdollah; Alberto Briganti; Al'a Abdo; Francesco Montorsi; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Zhe Tian; Pierre I Karakiewicz
Pelvic lymph node dissection for prostate cancer: adherence and accuracy of the recent guidelines.
International journal of urology : official journal of the Japanese Urological Association 2013;20(4):405-10.
2013: Maxine Sun; Quoc-Dien Trinh; Firas Abdollah; Marco Bianchi; Jens Hansen; Giovanni Lughezzani; Francesco Montorsi; Paul Perrotte; Shahrokh F Shariat; Pierre I Karakiewicz
Nodal involvement at nephrectomy is associated with worse survival: a stage-for-stage and grade-for-grade analysis.
International journal of urology : official journal of the Japanese Urological Association 2013;20(4):372-80.
2013: David A Green; Pierre I Karakiewicz; Surena F Matin; Michael Rink; Morgan Roupret; Douglas S Scherr; Arnulf Stenzl; evanguelos xylinas; Shahrokh F Shariat
Urothelial carcinoma of the bladder and the upper tract: disparate twins.
The Journal of urology 2013;189(4):1214-21.
2013: Michael Rink; Brian D Robinson; Douglas S Scherr; evanguelos xylinas; Emily C Zabor; Marko Babjuk; Felix K Chun; Helena Furberg; Pierre I Karakiewicz; Yair Lotan; Francesco Montorsi; Giacomo Novara; Armin Pycha; Shahrokh F Shariat
Impact of smoking and smoking cessation on oncologic outcomes in primary non-muscle-invasive bladder cancer.
European urology 2013;63(4):724-32.
2013: Behfar Ehdaie; Helena Furberg; Jamie S Ostroff; Shahrokh F Shariat; Emily Craig Zabor; Bernard H Bochner; Jonathan A Coleman; Guido Dalbagni
Impact of smoking status at diagnosis on disease recurrence and death in upper tract urothelial carcinoma.
BJU international 2013;111(4):589-95.
2013: M Rink; Shahrokh F Shariat; fianceeyi chun; Margit Fisch; L A Kluth; P Dahm
[Use of PubMed to improve evidence-based medicine in routine urological practice].
Der Urologe. Ausg. A 2013;52(3):367-72.
2013: evanguelos xylinas; Marc Zerbib; Robert S Svatek; Derya Tilki; Quoc D Trinh; Joual Abdennabi; Marko Babjuk; Thomas Clozel; Hans-Martin Fritsche; David A Green; Bertrand Guillonneau; Pierre I Karakiewicz; Wassim Kassouf; Yair Lotan; Francesco Montorsi; Giacomo Novara; Michael Rink; Douglas S Scherr; Shahrokh F Shariat
Predictors of survival in patients with soft tissue surgical margin involvement at radical cystectomy.
Annals of surgical oncology 2013;20(3):1027-34.
2013: David A Green; Eugene K Cha; Bilal Chughtai; Michael Rink; Douglas S Scherr; Shahrokh F Shariat; evanguelos xylinas; Richard K Lee
Cost-effective treatment of low-risk carcinoma not invading bladder muscle.
BJU international 2013;111(3 Pt B):E78-84.
2013: Michael Rink; Douglas S Scherr; Shahrokh F Shariat; Daniel D Sjoberg; Scott T Tagawa; Derya Tilki; Quoc-Dien Trinh; evanguelos xylinas; Atiqullah Aziz; Marko Babjuk; Jack Baniel; Patrick J Bastian; Antonin Brisuda; Eugene K Cha; Felix K Chun; Vincenzo Ficarra; Hans-Martin Fritsche; Paolo Gontero; David A Green; Jens Hansen; Pierre I Karakiewicz; Matthew Kent; Daniel J Lee; Yair Lotan; Roy Mano; Giacomo Novara; Armin Pycha
Predictors of cancer-specific mortality after disease recurrence following radical cystectomy.
BJU international 2013;111(3 Pt B):E30-6.
2013: Bassel G Bachir; Peter C Black; Wassim Kassouf; Jay B Shah; Shahrokh F Shariat; Robert Svatek; Alexandre Zlotta
Demographic analysis of randomized controlled trials in bladder cancer.
BJU international 2013;111(3):419-26.
2013: David A Green; Jens Hansen; Pierre I Karakiewicz; Michael Rink; Brian Robinson; Douglas S Scherr; Eugene K Cha; Felix K Chun; Margit Fisch; Scott Tagawa; Zhe Tian; Shahrokh F Shariat
Accurate preoperative prediction of non-organ-confined bladder urothelial carcinoma at cystectomy.
BJU international 2013;111(3):404-11.
2013: Luis A Kluth; evanguelos xylinas; Shahrokh F Shariat
Words of wisdom: re: a prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
European urology 2013;63(2):399-400.
2013: evanguelos xylinas; Marc Zerbib; Evi Comploj; Talia Faison; Mithat Gonen; Bertrand Guillonneau; Pierre I Karakiewicz; Yair Lotan; Vitaly Margulis; Francesco Montorsi; Giacomo Novara; Armin Pycha; Jay D Raman; Michael Rink; Douglas S Scherr; Christian Seitz; Shahrokh F Shariat; Maxine Sun; Quoc-Dien Trinh; Alon Z Weizer
Prediction of true nodal status in patients with pathological lymph node negative upper tract urothelial carcinoma at radical nephroureterectomy.
The Journal of urology 2013;189(2):468-73.
2013: Morgan Rouprêt; Pierre Colin; Pierre Karakiewicz; Luis Kluth; evanguelos xylinas; Shahrokh F Shariat
Oncologic outcomes and survival in pT0 tumors after radical nephroureterectomy for upper tract urothelial carcinoma: results from of a large multicenter international collaborative study.
European urology 2013;63(2):404-5.
2013: Harun Fajkovic; Hans-Martin Fritsche; Pierre I Karakiewicz; Wassim Kassouf; Yair Lotan; Vitaly Margulis; Francesco Montorsi; Giacomo Novara; Wolfgang Otto; Armin Pycha; Jay D Raman; Michael Rink; Morgan Roupret; Douglas S Scherr; Christian Seitz; Shiro Baba; Karim Bensalah; Christian Bolenz; Joaquin Carballido; Eugene K Cha; Allison Dunning; Guru Sonpavde; Quoc-Dien Trinh; Thomas J Walton; evanguelos xylinas; Richard Zigeuner; Shahrokh F Shariat
Disease-free survival as a surrogate for overall survival in upper tract urothelial carcinoma.
World journal of urology 2013;31(1):5-11.
2013: evanguelos xylinas; Pierre I Karakiewicz; Luis Kluth; Sibani Mangal; Morgan Roupret; Shahrokh F Shariat
Predictive tools for clinical decision-making and counseling of patients with upper tract urothelial carcinoma.
World journal of urology 2013;31(1):31-6.
2013: Sean C Skeldon; Theodorus H Van Der Kwast; Bas W G van Rhijn; Melyssa Aronson; Bharati Bapat; Peter Bostrom; Jim Catto; Zane Cohen; Andrew Evans; Neil E Fleshner; Steven Gallinger; Sally Hanna; Spring Holter; Michael A Jewett; Cynthia Kuk; Aaron Pollett; Kara Semotiuk; Shahrokh F Shariat; Alexandre R Zlotta
Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer.
European urology 2013;63(2):379-85.
2013: Jens Hansen; Hartwig Huland; Michael Marberger; Leonard S Marks; Peter F A Mulders; Alan W Partin; Karl Pummer; Jack A Schalken; Shahrokh F Shariat; Arnulf Stenzl; Hendrik van Poppel; Jochen Walz; Clement-Claude Abbou; Sascha A Ahyai; Marco Auprich; Alberto Briganti; Alexandre de la Taille; William Ellis; Margit Fisch; Yves Fradet; Markus Graefen; Alexander Haese; fianceeyi chun
Initial prostate biopsy: development and internal validation of a biopsy-specific nomogram based on the prostate cancer antigen 3 assay.
European urology 2013;63(2):201-9.
2013: Shahrokh F Shariat; Guru Sonpavde; Robert S Svatek; Scott T Tagawa; Quoc-Dien Trinh; evanguelos xylinas; Marko Babjuk; Eugene K Cha; fianceeyi chun; Siamak Daneshmand; Behfar Ehdaie; Harun Fajkovic; Hans-Martin Fritsche; Abdennabi Joual; Pierre I Karakiewicz; Wassim Kassouf; Yair Lotan; Axel S Merseburger; Giacomo Novara; Michael Rink; Douglas S Scherr; Mithat Gonen
Pathologic nodal staging score for bladder cancer: a decision tool for adjuvant therapy after radical cystectomy.
European urology 2013;63(2):371-8.
2013: Thomas F Chromecki; Siamak Daneshmand; Matthieu Durand; Behfar Ehdaie; Harun Fajkovic; Hans-Martin Fritsche; Jonathan I Izawa; Pierre I Karakiewicz; Wassim Kassouf; Yair Lotan; Giacomo Novara; Karl Pummer; Michael Rink; Marko Babjuk; Patrick J Bastian; Antonin Brisuda; Maximilian Burger; Eugene K Cha; Robert S Svatek; Derya Tilki; Shahrokh F Shariat
Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy.
BJU international 2013;111(2):249-55.
2013: Rodolphe Thuret; Firas Abdollah; Lars Budaus; Jacques Guiter; François Iborra; Daniel Liberman; Jean-Jacques Patard; Paul Perrotte; Shahrokh F Shariat; Maxine Sun; Pierre I Karakiewicz
A population-based analysis of the effect of marital status on overall and cancer-specific mortality in patients with squamous cell carcinoma of the penis.
Cancer causes & control : CCC 2013;24(1):71-9.
2013: Ashish M Kamat; Peter E Clark; Michael Droller; Jason R Gee; Nicholas Hegarty; Paul K Hegarty; Lawrence C Jenkins; Yair Lotan; Bernd J Schmitz-Dräger; Shahrokh F Shariat; Robert S Svatek; Bas W G van Rhijn; evanguelos xylinas; Pierre I Karakiewicz
ICUD-EAU International Consultation on Bladder Cancer 2012: screening, diagnosis, and molecular markers.
European urology 2013;63(1):4-15.
2013: Jens Hansen; Pierre I Karakiewicz; Luis A Kluth; Michael Rink; Shahrokh F Shariat; Thomas Steuber; Zhe Tian; Sascha A Ahyai; Marco Bianchi; Alberto Briganti; Margit Fisch; Markus Graefen; Felix K-H Chun
External validation of the updated Briganti nomogram to predict lymph node invasion in prostate cancer patients undergoing extended lymph node dissection.
The Prostate 2013;73(2):211-8.
2013: Michael Rink; Douglas S Scherr; Robert S Svatek; Scott T Tagawa; Derya Tilki; evanguelos xylinas; Marko Babjuk; Patrick J Bastian; Eugene K Cha; fianceeyi chun; Evi Comploj; Roland Dahlem; Siamak Daneshmand; Talia Faison; Hans-Martin Fritsche; David A Green; Jens Hansen; Pierre I Karakiewicz; Wassim Kassouf; Yair Lotan; Giacomo Novara; Armin Pycha; Shahrokh F Shariat
Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy.
BJU international 2013;111(1):74-84.
2013: Behfar Ehdaie; Shahrokh F Shariat
Magnetic resonance imaging-targeted prostate biopsy: back to the future.
European urology 2013;63(1):141-2; discussion 143-4.
2013: Maxine Sun; Zhe Tian; Quoc-Dien Trinh; Francesco Montorsi; Paul Perrotte; Shahrokh F Shariat; Firas Abdollah; Marco Bianchi; Nawar Hanna; Jens Hansen; Pierre I Karakiewicz
Comparison of partial vs radical nephrectomy with regard to other-cause mortality in T1 renal cell carcinoma among patients aged ≥75 years with multiple comorbidities.
BJU international 2013;111(1):67-73.
2012: Eugene K Cha; Paul J Christos; Joerg Hennenlotter; Thomas Martini; Christine Mian; Armin Pycha; Christian Schwentner; Shahrokh F Shariat; Arnulf Stenzl; Lenuta-Ancuta Tirsar; Bernd J Schmitz-Dräger
Accurate risk assessment of patients with asymptomatic hematuria for the presence of bladder cancer.
World journal of urology 2012;30(6):847-52.
2012: Michael Rink; Douglas S Scherr; Maxine Sun; evanguelos xylinas; Joual Abdennabi; Marko Babjuk; fianceeyi chun; Evi Comploj; Harun Fajkovic; Margit Fisch; Jens Hansen; Pierre I Karakiewicz; Wolfgang Loidl; Yair Lotan; Armin Pycha; Shahrokh F Shariat
Impact of smoking on outcomes of patients with a history of recurrent nonmuscle invasive bladder cancer.
The Journal of urology 2012;188(6):2120-7.
2012: Michael Rink; evanguelos xylinas; Marko Babjuk; Roland Dahlem; Pierre I Karakiewicz; Giacomo Novara; Armin Pycha; Shahrokh F Shariat
Smoking reduces the efficacy of intravesical bacillus Calmette-Guérin immunotherapy in non-muscle-invasive bladder cancer.
European urology 2012;62(6):1204-6.
2012: David R Yates; Alexandre R Zlotta; Maurizio Brausi; James W F Catto; Guido Dalbagni; Morgan Rouprêt; Shahrokh F Shariat; Richard J Sylvester; J Alfred Witjes; Juan Palou Redorta
Treatment options available for bacillus Calmette-Guérin failure in non-muscle-invasive bladder cancer.
European urology 2012;62(6):1088-96.
2012: Mehrad Adibi; Christian Bolenz; Yair Lotan; Francesco Montorsi; Arthur I Sagalowsky; Shahrokh F Shariat; Christopher G Wood; Ramy Youssef; Richard Zigeuner; Vitaly Margulis
Oncological outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: comparison over the three decades.
International journal of urology : official journal of the Japanese Urological Association 2012;19(12):1060-6.
2012: Michael Rink; Douglas S Scherr; Shahrokh F Shariat; Scott T Tagawa; Derya Tilki; Quoc-Dien Trinh; Bjoern G Volkmer; evanguelos xylinas; Marko Babjuk; Patrick J Bastian; Felix K Chun; Siamak Daneshmand; John P Fitzgerald; Yves Fradet; Hans-Martin Fritsche; David A Green; Jens Hansen; Ashish M Kamat; Pierre I Karakiewicz; Wassim Kassouf; Yair Lotan; Axel S Merseburger; Giacomo Novara; Robert S Svatek
Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy?
World journal of urology 2012;30(6):807-14.
2012: Michael Rink; Douglas S Scherr; Christian Seitz; Daniel Sjoberg; Andrew J Vickers; evanguelos xylinas; Richard Zigeuner; Karim Bensalah; Eugene K Cha; Felix K Chun; Evi Comploj; Jens Hansen; Pierre I Karakiewicz; Wassim Kassouf; Eiji Kikuchi; Richard K Lee; Yair Lotan; Vitaly Margulis; Juan I Martinez-Salamanca; Surena F Matin; Giacomo Novara; Armin Pycha; Jay D Raman; Mesut Remzi; Shahrokh F Shariat
Risk of cancer-specific mortality following recurrence after radical nephroureterectomy.
Annals of surgical oncology 2012;19(13):4337-44.
2012: Thomas F Chromecki; Colin P Dinney; Harun Fajkovic; Vincenzo Ficarra; Yves Fradet; Hans-Martin Fritsche; Pierre I Karakiewicz; Wassim Kassouf; Yair Lotan; Julian Mauermann; Francesco Montorsi; Giacomo Novara; Karl Pummer; Eila Skinner; Christian G Stief; Robert S Svatek; Derya Tilki; Bjoern G Volkmer; Patrick J Bastian; Eugene K Cha; Shahrokh F Shariat
Multicenter validation of the prognostic value of patient age in patients treated with radical cystectomy.
World journal of urology 2012;30(6):753-9.
2012: Oliver Patschan; Shahrokh F Shariat; Ulf-Håkan Stenman; Raheela Ashfaq; Daher C Chade; Kristina Hotakainen; Pierre I Karakiewicz; Yair Lotan; Anders Bjartell
Association of tumor-associated trypsin inhibitor (TATI) expression with molecular markers, pathologic features and clinical outcomes of urothelial carcinoma of the urinary bladder.
World journal of urology 2012;30(6):785-94.
2012: David A Green; Pierre I Karakiewicz; E Charles Osterberg; Michael Rink; Douglas S Scherr; evanguelos xylinas; Shahrokh F Shariat
Predictive tools for prostate cancer staging, treatment response and outcomes.
Archivos españoles de urología 2012;65(9):787-807.
2012: evanguelos xylinas; Luis Kluth; Morgan Rouprêt; Douglas S Scherr; Shahrokh F Shariat
Collaborative research networks as a platform for virtual multidisciplinary, international approach to managing difficult clinical cases: an example from the Upper Tract Urothelial Carcinoma Collaboration.
European urology 2012;62(5):943-5.
2012: evanguelos xylinas; Shahrokh F Shariat; Marc Zerbib
Uptake of laparoscopic radical nephroureterectomy in France: a 2003-2011 national practice report.
European urology 2012;62(5):940-2.
2012: Maxine Sun; Zhe Tian; Quoc-Dien Trinh; Francesco Montorsi; Paul Perrotte; Shahrokh F Shariat; Firas Abdollah; Marco Bianchi; Alberto Briganti; Jens Hansen; Pierre I Karakiewicz
Is a treatment delay in radical prostatectomy safe in individuals with low-risk prostate cancer?
The journal of sexual medicine 2012;9(11):2961-9.
2012: David A Green; Naveen Gumpeni; Pierre I Karakiewicz; Michael Rink; Douglas S Scherr; Eugene K Cha; Matthieu Durand; Shahrokh F Shariat
Role of magnetic resonance imaging in bladder cancer: current status and emerging techniques.
BJU international 2012;110(10):1463-70.
2012: Jesse D Sammon; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Quoc-Dien Trinh; Marco Bianchi; Orchidee Djahangirian; Michael Ehlert; Khurshid R Ghani; Wooju Jeong; Jay Jhaveri; Mani Menon; Monica Morgan; James O Peabody; Paul Perrotte; Craig G Rogers; Pierre I Karakiewicz
Marital status: a gender-independent risk factor for poorer survival after radical cystectomy.
BJU international 2012;110(9):1301-9.
2012: Quoc-Dien Trinh; Piyush K Agarwal; Marco Bianchi; Khurshid R Ghani; Claudio Jeldres; Wooju Jeong; Mani Menon; James O Peabody; Paul Perrotte; Craig G Rogers; Jesse Sammon; Shahrokh F Shariat; Maxine Sun; Zhe Tian; Pierre I Karakiewicz
Leapfrog volume thresholds and perioperative complications after radical prostatectomy.
Cancer 2012;118(20):4991-8.
2012: Maxine Sun; Zhe Tian; Quoc-Dien Trinh; Firas Abdollah; Marco Bianchi; Markus Graefen; Jens Hansen; Francesco Montorsi; Paul Perrotte; Jesse Sammon; Shahrokh F Shariat; Pierre I Karakiewicz
Chronic kidney disease after nephrectomy in patients with small renal masses: a retrospective observational analysis.
European urology 2012;62(4):696-703.
2012: Ramy Youssef; Ahmed Mosbah; Shahrokh F Shariat; Hassan Abol-Enein; Tyler Arendt; Mohamed Ghoneim; Wareef Kabbani; Payal Kapur; Yair Lotan
Prognostic value of apoptotic markers in squamous cell carcinoma of the urinary bladder.
BJU international 2012;110(7):961-6.
2012: Michael Rink; Douglas S Scherr; Shahrokh F Shariat; Robert S Svatek; Marko Babjuk; Eugene K Cha; Siamak Daneshmand; Behfar Ehdaie; Harun Fajkovic; Margit Fisch; Hans-Martin Fritsche; David A Green; Jens Hansen; Pierre I Karakiewicz; Wassim Kassouf; Richard K Lee; Yair Lotan; Vitaly Margulis; Giacomo Novara; Armin Pycha; Jay D Raman
Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery.
European urology 2012;62(4):677-84.
2012: Quoc-Dien Trinh; Piyush K Agarwal; Marco Bianchi; Ali Dabaja; Khurshid R Ghani; Wooju Jeong; Mani Menon; James O Peabody; Paul Perrotte; Craig G Rogers; Jesse Sammon; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Pierre I Karakiewicz
Disparities in access to care at high-volume institutions for uro-oncologic procedures.
Cancer 2012;118(18):4421-6.
2012: Shyam Sukumar; Maxine Sun; Marco Bianchi; Felix K Chun; Jack S Elder; Ariella A Friedman; Khurshid R Ghani; Jens Hansen; Wooju Jeong; Pierre I Karakiewicz; Mani Menon; James O Peabody; Praful Ravi; Jesse Sammon; Shahrokh F Shariat; Quoc-Dien Trinh
National trends and disparities in the use of minimally invasive adult pyeloplasty.
The Journal of urology 2012;188(3):913-8.
2012: Giacomo Novara; Raymond C Rosen; Shahrokh F Shariat; Jens-Uwe Stolzenburg; Hendrik Van Poppel; Filiberto Zattoni; Walter Artibani; Anthony Costello; James A Eastham; Vincenzo Ficarra; Markus Graefen; Giorgio Guazzoni; Francesco Montorsi; Alexandre Marie Mottrie; Timothy G Wilson
Systematic review and meta-analysis of perioperative outcomes and complications after robot-assisted radical prostatectomy.
European urology 2012;62(3):431-52.
2012: Giacomo Novara; Vipul R Patel; Raymond C Rosen; Shahrokh F Shariat; Ashutosh K Tewari; Hendrik Van Poppel; Filiberto Zattoni; Thomas E Ahlering; Peter R Carroll; Vincenzo Ficarra; Markus Graefen; Giorgio Guazzoni; Mani Menon; Simone Mocellin; Francesco Montorsi; Alexandre Marie Mottrie; Timothy G Wilson
Systematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatectomy.
European urology 2012;62(3):382-404.
2012: M Rink; Thorsten Schlomm; M Adam; Sascha A Ahyai; fianceeyi chun; R Dahlem; Christian Eichelberg; O Engel; Margit Fisch; J Hansen; R Heuer; M Remzi; Shahrokh F Shariat
[Upper tract urothelial carcinoma. An update on clinical and pathological prognostic factors].
Der Urologe. Ausg. A 2012;51(9):1228-39.
2012: Firas Abdollah; Alberto Briganti; Claudio Jeldres; Francesco Montorsi; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Zhe Tian; Pierre I Karakiewicz
Comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer: a population-based analysis.
International journal of urology : official journal of the Japanese Urological Association 2012;19(9):836-44; author reply 844-5.
2012: Marco Roscigno; Douglas S Scherr; Christian Seitz; Thomas J Walton; Roberto Bertini; Joaquin Carballido; Eugene K Cha; Thomas F Chromecki; Harun Fajkovic; Vincenzo Ficarra; Luigi Filippo Da Pozzo; Hans-Martin Fritsche; Pierre I Karakiewicz; Kazumasa Matsumoto; Francesco Montorsi; Richard Naspro; Giacomo Novara; Wolfgang Otto; Armin Pycha; Michael Rink; Shahrokh F Shariat
International validation of the prognostic value of subclassification for AJCC stage pT3 upper tract urothelial carcinoma of the renal pelvis.
BJU international 2012;110(5):674-81.
2012: Firas Abdollah; Alberto Briganti; Claudio Jeldres; Francesco Montorsi; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Rodolphe Thuret; Zhe Tian; Pierre I Karakiewicz
Competing-risks mortality after radiotherapy vs. observation for localized prostate cancer: a population-based study.
International journal of radiation oncology, biology, physics 2012;84(1):95-103.
2012: Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Quoc-Dien Trinh; Mani Menon; Francesco Montorsi; Paul Perrotte; Marco Bianchi; Felix K Chun; Roland Dahlem; Margit Fisch; Markus Graefen; Jens Hansen; Claudio Jeldres; Pierre I Karakiewicz
Higher perioperative morbidity and in-hospital mortality in patients with end-stage renal disease undergoing nephrectomy for non-metastatic kidney cancer: a population-based analysis.
BJU international 2012;110(6 Pt B):E183-90.
2012: Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Quoc-Dien Trinh; Firas Abdollah; Marco Bianchi; Lars Budäus; Markus Graefen; Mani Menon; Francesco Montorsi; Paul Perrotte; Georg Salomon; Thorsten Schlomm; Pierre I Karakiewicz
Venous thromboembolism after radical prostatectomy: the effect of surgical caseload.
BJU international 2012;110(6):828-33.
2012: Hans-Martin Fritsche; Amit Gupta; Arndt Hartmann; Pierre I Karakiewicz; Wassim Kassouf; Juan I Martínez Salamanca; Kazumasa Matsumoto; Giacomo Novara; Wolfgang Otto; Christian Seitz; Shiro Baba; Patrick J Bastian; Maximilian Burger; Vincenzo Ficarra; Kanishka Sircar; Stefan Tritschler; Tom Walton; Wolf Ferdinand Wieland; Filiberto Zattoni; Shahrokh F Shariat
Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma.
Urologic oncology 2012;30(5):666-72.
2012: Marco Bianchi; Alberto Briganti; Markus Graefen; Claudio Jeldres; Mani Menon; Malek Meskawi; Francesco Montorsi; James O Peabody; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Zhe Tian; Quoc-Dien Trinh; Pierre I Karakiewicz
Impact of academic affiliation on radical cystectomy outcomes in North America: A population-based study.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada 2012;6(4):245-50.
2012: Jesse Sammon; Jan Schmitges; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Quoc-Dien Trinh; Marco Bianchi; Alberto Briganti; Khurshid R Ghani; Claudio Jeldres; Mani Menon; Francesco Montorsi; James O Peabody; Paul Perrotte; Craig G Rogers; Pierre I Karakiewicz
The effect of gender on nephrectomy perioperative outcomes: a national survey.
The Canadian journal of urology 2012;19(4):6337-44.
2012: Shahrokh F Shariat; evanguelos xylinas
Biomarkers in personalised treatment of renal-cell carcinoma.
The lancet oncology 2012;13(8):751-2.
2012: Michael Rink; Nathalie Rioux-Leclercq; Brian D Robinson; Douglas S Scherr; Kanishka Sircar; Guru Sonpavde; Maxine Sun; Karim Bensalah; Eugene K Cha; Felix K Chun; Evi Comploj; David A Green; Charles C Guo; Andrea Haitel; Jens Hansen; Wareef Kabbani; Pierre I Karakiewicz; Wassim Kassouf; Eiji Kikuchi; Yair Lotan; Vitaly Margulis; Casey K Ng; Armin Pycha; Jay D Raman; Mesut Remzi; Shahrokh F Shariat
Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma.
The Journal of urology 2012;188(2):398-404.
2012: Jens Hansen; Marco Bianchi; Felix K-H Chun; Markus Graefen; Nawar Hanna; Malek Meskawi; Paul Perrotte; Michael Rink; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Zhe Tian; Pierre I Karakiewicz
Assessment of cancer control outcomes in patients with high-risk renal cell carcinoma treated with partial nephrectomy.
Urology 2012;80(2):347-53.
2012: Malek Meskawi; Francesco Montorsi; Paul Perrotte; Michael Rink; Shahrokh F Shariat; Maxine Sun; Zhe Tian; Quoc-Dien Trinh; Marco Bianchi; Jens Hansen; Salima Ismail; Pierre I Karakiewicz
A review of integrated staging systems for renal cell carcinoma.
European urology 2012;62(2):303-14.
2012: Shahrokh F Shariat; Kanishka Sircar; Christopher G Wood; Richard Zigeuner; Vitaly Margulis; Shuji Mikami; Casey K Ng; Jay D Raman; Mesut Remzi; Michael Rink; Douglas S Scherr; Karim Bensalah; Felix K Chun; Charles C Guo; Andrea Haitel; Jens Hansen; Wareef Kabbani; Pierre I Karakiewicz; Wassim Kassouf; Eiji Kikuchi; Theresa Koppie; Cord Langner
Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revision of the current TNM classification.
European urology 2012;62(2):224-31.
2012: Quoc-Dien Trinh; Kevin Zorn; Marco Bianchi; Markus Graefen; Claudio Jeldres; Mani Menon; James O Peabody; Paul Perrotte; Craig G Rogers; Jesse Sammon; Jan Schmitges; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Pierre I Karakiewicz
Does partial nephrectomy at an academic institution result in better outcomes?
World journal of urology 2012;30(4):505-10.
2012: Firas Abdollah; Marco Bianchi; Alberto Briganti; Claudio Jeldres; Francesco Montorsi; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Rodolphe Thuret; Pierre I Karakiewicz
Survival benefit of radical prostatectomy in patients with localized prostate cancer: estimations of the number needed to treat according to tumor and patient characteristics.
The Journal of urology 2012;188(1):73-83.
2012: Aditya Bagrodia; Michael J Belsante; Chase Cannon; Oussama M Darwish; Deniz Gerecci; Payal Kapur; Yair Lotan; Arthur I Sagalowsky; Shahrokh F Shariat; Ramy F Youssef; Vitaly Margulis
Prospective evaluation of molecular markers for the staging and prognosis of upper tract urothelial carcinoma.
European urology 2012;62(1):e27-9.
2012: evanguelos xylinas; Karim Bensalah; Pierre I Karakiewicz; Vitaly Margulis; Michael Rink; Shahrokh F Shariat
Histologic variants of upper tract urothelial carcinoma do not affect response to adjuvant chemotherapy after radical nephroureterectomy.
European urology 2012;62(1):e25-6.
2012: Firas Abdollah; Alberto Briganti; Claudio Jeldres; Francesco Montorsi; Paul Perrotte; Shahrokh F Shariat; Maxine Sun; Rodolphe Thuret; Zhe Tian; Pierre I Karakiewicz
Lymph node count threshold for optimal pelvic lymph node staging in prostate cancer.
International journal of urology : official journal of the Japanese Urological Association 2012;19(7):645-51.
2012: Giovanni Lughezzani; Vitaly Margulis; Surena F Matin; Giacomo Novara; Morgan Roupret; Shahrokh F Shariat; Christopher G Wood; Maximilian Burger; Richard Zigeuner
Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature.
European urology 2012;62(1):100-14.
2012: Maxine Sun; Rodolphe Thuret; Zhe Tian; Quoc-Dien Trinh; Firas Abdollah; Marco Bianchi; Claudio Jeldres; Francesco Montorsi; Paul Perrotte; Shahrokh F Shariat; Pierre I Karakiewicz
Treatment management of small renal masses in the 21st century: a paradigm shift.
Annals of surgical oncology 2012;19(7):2380-7.
2012: Maxine Sun; Zhe Tian; Quoc-Dien Trinh; Francesco Montorsi; Paul Perrotte; Shahrokh F Shariat; Firas Abdollah; Marco Bianchi; Alberto Briganti; Markus Graefen; Jens Hansen; Claudio Jeldres; Pierre I Karakiewicz
Conditional survival of patients with urothelial carcinoma of the urinary bladder treated with radical cystectomy.
European journal of cancer (Oxford, England : 1990) 2012;48(10):1503-11.
2012: Faysal A Yafi; Filiberto Zattoni; Assaad El-Hakim; Vincenzo Ficarra; Hans-Martin Fritsche; Amit Gupta; Pierre I Karakiewicz; Juan I Martínez Salamanca; Kazumasa Matsumoto; Giacomo Novara; Christian Seitz; Shahrokh F Shariat; Stefan Trischler; Thomas J Walton; Wassim Kassouf
Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.
BJU international 2012;110(2 Pt 2):E7-13.
2012: Thomas F Chromecki; Harun Fajkovic; Pierre I Karakiewicz; Karl Pummer; Claus G Roehrborn; Douglas S Scherr; Raheela Ashfaq; Eugene K Cha; Maxine Sun; Ashutosh K Tewari; Shahrokh F Shariat
Prognostic value of insulin-like growth factor II mRNA binding protein 3 in patients treated with radical prostatectomy.
BJU international 2012;110(1):63-8.
2012: Quoc-Dien Trinh; Kevin Zorn; Marco Bianchi; Markus Graefen; Claudio Jeldres; Mani Menon; James O Peabody; Paul Perrotte; Craig G Rogers; Jesse Sammon; Jan Schmitges; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Pierre I Karakiewicz
Node-positive renal cell carcinoma in the absence of distant metastases: predictors of cancer-specific mortality in a population-based cohort.
BJU international 2012;110(2 Pt 2):E21-7.
2012: Yair Lotan; Shahrokh F Shariat; Robert S Svatek; Catherine M Tangen; Ian M Thompson; Ramy F Youssef; Phyllis J Goodman; Eric A Klein
Evaluation of vitamin E and selenium supplementation for the prevention of bladder cancer in SWOG coordinated SELECT.
The Journal of urology 2012;187(6):2005-10.
2012: M Rink; T F Chromecki; fianceeyi chun; R Dahlem; Harun Fajkovic; Margit Fisch; Shahrokh F Shariat
[Advanced bladder cancer in elderly patients. Prognostic outcomes and therapeutic strategies].
Der Urologe. Ausg. A 2012;51(6):820-8.
2012: Jan Schmitges; Shahrokh F Shariat; Thomas Steuber; Maxine Sun; Quoc-Dien Trinh; Firas Abdollah; Sascha A Ahyai; Marco Bianchi; Markus Graefen; Claudio Jeldres; Mani Menon; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
The effect of annual surgical caseload on the rates of in-hospital pneumonia and other in-hospital outcomes after radical prostatectomy.
International urology and nephrology 2012;44(3):799-806.
2012: Maxine Sun; Zhe Tian; Hugues Widmer; Kevin Zorn; Firas Abdollah; Marco Bianchi; Markus Graefen; Francesco Montorsi; Paul Perrotte; Daniel Pharand; Jan Schmitges; Shahrokh F Shariat; Pierre I Karakiewicz
Cytoreductive nephrectomy in the elderly: a population-based cohort from the USA.
BJU international 2012;109(12):1807-12.
2012: Marco Auprich; Lars Budäus; Herbert Augustin; Margit Fisch; Markus Graefen; Luis Kluth; Sebastian Mannweiler; Karl Pummer; Shahrokh F Shariat; fianceeyi chun
A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy.
BJU international 2012;109(11):1627-35.
2012: evanguelos xylinas; Pierre Karakiewicz; Vitaly Margulis; Giacomo Novara; Michael Rink; Shahrokh F Shariat
Multifocal carcinoma in situ of the upper tract is associated with high risk of bladder cancer recurrence.
European urology 2012;61(5):1069-70.
2012: Daher C Chade; James Eastham; Markus Graefen; Jim C Hu; R Jeffrey Karnes; Laurence Klotz; Francesco Montorsi; Peter T Scardino; Hendrik van Poppel; Shahrokh F Shariat
Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature.
European urology 2012;61(5):961-71.
2012: Quoc-Dien Trinh; Marco Bianchi; Markus Graefen; Mani Menon; James O Peabody; Paul Perrotte; Craig G Rogers; Jesse Sammon; Jan Schmitges; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Zhe Tian; Pierre I Karakiewicz
Open radical prostatectomy in the elderly: a case for concern?
BJU international 2012;109(9):1335-40.
2012: Jeffery C Wheat; J Stuart Wolf; Christopher G Wood; Richard Zigeuner; Alon Z Weizer; Karim Bensalah; Christian Bolenz; Umberto Capitanio; Mario Fernández; Pierre Karakiewizc; Eiji Kikuchi; Theresa Koppie; Cord Langner; Yair Lotan; Vitaly Margulis; Francesco Montorsi; Jean-Jacques Patard; Jay D Raman; Mesut Remzi; Marco Roscigno; Shahrokh F Shariat
Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy.
Urologic oncology 2012;30(3):252-8.
2012: Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Quoc-Dien Trinh; Firas Abdollah; Marco Bianchi; Lars Budäus; Christian Eichelberg; Markus Graefen; Jens Hansen; Mani Menon; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Annual prostatectomy volume is related to rectal laceration rate after radical prostatectomy.
Urology 2012;79(4):796-803.
2012: Michael Rink; Brian D Robinson; Arthur I Sagalowsky; Douglas S Scherr; Eugene K Cha; Felix K Chun; Margit Fisch; David Green; Jens Hansen; Pierre I Karakiewicz; Yair Lotan; Shahrokh F Shariat
Biomolecular predictors of urothelial cancer behavior and treatment outcomes.
Current urology reports 2012;13(2):122-35.
2012: Marco Bianchi; Alberto Briganti; Khurshid R Ghani; Claudio Jeldres; Mani Menon; Francesco Montorsi; James O Peabody; Paul Perrotte; Craig G Rogers; Jesse Sammon; Jan Schmitges; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Quoc-Dien Trinh; Pierre I Karakiewicz
Discharge patterns after radical cystectomy: contemporary trends in the United States.
The Journal of urology 2012;187(4):1206-9.
2012: Michael Rink; Shahrokh F Shariat; Armin Soave; Malgorzata Stoupiec; Sascha A Ahyai; fianceeyi chun; Cornelia Coith; Roland Dahlem; Margit Fisch; Martin G Friedrich; Jens Hansen; Luis A Kluth; Sarah Minner; Klaus Pantel; Sabine Riethdorf
Prognostic role and HER2 expression of circulating tumor cells in peripheral blood of patients prior to radical cystectomy: a prospective study.
European urology 2012;61(4):810-7.
2012: Michael Rink; Eugene K Cha; fianceeyi chun; Harun Fajkovic; Amit Gupta; Pierre I Karakiewicz; Yair Lotan; Shahrokh F Shariat
Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma.
European urology 2012;61(4):854-5.
2012: Nawar Hanna; Jens Hansen; Marco Bianchi; Markus Graefen; Francesco Montorsi; Paul Perrotte; Shahrokh F Shariat; Maxine Sun; Quoc-Dien Trinh; Pierre I Karakiewicz
Propensity-score-matched comparison of perioperative outcomes between open and laparoscopic nephroureterectomy: a national series.
European urology 2012;61(4):715-21.
2012: Quoc-Dien Trinh; Marco Bianchi; Khurshid R Ghani; Jens Hansen; Claudio Jeldres; Wooju Jeong; Mani Menon; Francesco Montorsi; James O Peabody; Praful Ravi; Craig G Rogers; Jesse Sammon; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Pierre I Karakiewicz
Perioperative outcomes of robot-assisted radical prostatectomy compared with open radical prostatectomy: results from the nationwide inpatient sample.
European urology 2012;61(4):679-85.
2012: Thomas Clements; Scott E Eggener; Michael P Herman; Yair Lotan; Steven M Lucas; Jamie C Messer; Casey K Ng; Douglas S Scherr; Benjamin Scoll; Shahrokh F Shariat; John D Terrell; Robert G Uzzo; Mark Wille; Stephen A Boorjian; Jay D Raman
High-grade ureteroscopic biopsy is associated with advanced pathology of upper-tract urothelial carcinoma tumors at definitive surgical resection.
Journal of endourology / Endourological Society 2012;26(4):398-402.
2012: Maxine Sun; Quoc-Dien Trinh; Francesco Montorsi; Paul Perrotte; Shahrokh F Shariat; Firas Abdollah; Marco Bianchi; Alberto Briganti; Nawar Hanna; Jens Hansen; Pierre I Karakiewicz
A non-cancer-related survival benefit is associated with partial nephrectomy.
European urology 2012;61(4):725-31.
2012: Daniel J Lee; Douglas S Scherr; Scott T Tagawa; Himisha Beltran; Eugene K Cha; Thomas F Chromecki; Justin M Dubin; Harun Fajkovic; Shahrokh F Shariat
Novel therapeutics for the management of castration-resistant prostate cancer (CRPC).
BJU international 2012;109(7):968-85.
2012: Quoc-Dien Trinh; Kevin Zorn; Marco Bianchi; Markus Graefen; Mani Menon; James O Peabody; Paul Perrotte; Craig G Rogers; Jesse Sammon; Jan Schmitges; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Pierre I Karakiewicz
Morbidity and mortality of radical prostatectomy differs by insurance status.
Cancer 2012;118(7):1803-10.
2012: Quoc-Dien Trinh; Marco Bianchi; Markus Graefen; Claudio Jeldres; Mani Menon; James O Peabody; Paul Perrotte; Craig G Rogers; Jesse Sammon; Jan Schmitges; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Zhe Tian; Pierre I Karakiewicz
Improvement of racial disparities with respect to the utilization of minimally invasive radical prostatectomy in the United States.
Cancer 2012;118(7):1894-900.
2012: Al'a Abdo; Marco Bianchi; Claudio Jeldres; Mani Menon; James O Peabody; Paul Perrotte; Craig G Rogers; Jesse Sammon; Jan Schmitges; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Quoc-Dien Trinh; Kevin Zorn; Pierre I Karakiewicz
The effect of insurance status on outcomes after partial nephrectomy.
International urology and nephrology 2012;44(2):343-51.
2012: Firas Abdollah; Orchidee Djahangirian; Claudio Jeldres; Francesco Montorsi; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Zhe Tian; Pierre I Karakiewicz
Stage-specific impact of pelvic lymph node dissection on survival in patients with non-metastatic bladder cancer treated with radical cystectomy.
BJU international 2012;109(8):1147-54.
2012: Juan Ignacio Martinez-Salamanca; Kazumasa Matsumoto; Lucia Osorio Cabello; Thomas F Chromecki; Vincenzo Ficarra; Hans-Martin Fritsche; Wassim Kassouf; Joaquin Carballido Rodriguez; Christian Seitz; Shahrokh F Shariat; Stefan Tritschler; Thomas J Walton; Filiberto Zattoni; Giacomo Novara
Prognostic role of ECOG performance status in patients with urothelial carcinoma of the upper urinary tract: an international study.
BJU international 2012;109(8):1155-61.
2012: Firas Abdollah; Alberto Briganti; Al'a Abdo; Francesco Montorsi; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Zhe Tian; Pierre I Karakiewicz
A population-based assessment of the National Comprehensive Cancer Network practice guideline indications for pelvic lymph node dissection at radical prostatectomy.
BJU international 2012;109(8):1177-82.
2012: Michael Marberger; Shahrokh F Shariat; Jelle Barentsz; Mark Emberton; Jonas Hugosson; Laurence Klotz; Michael Koch; Stacy Loeb; Andrew Vickers
Novel approaches to improve prostate cancer diagnosis and management in early-stage disease.
BJU international 2012;109 Suppl 2():1-7.
2012: Harun Fajkovic; Vincenzo Ficarra; Claudio Jeldres; Pierre I Karakiewicz; Wassim Kassouf; Eiji Kikuchi; Yair Lotan; Vitaly Margulis; Kazumasa Matsumoto; Francesco Montorsi; Giacomo Novara; Armin Pycha; Jay D Raman; Mesut Remzi; Marco Roscigno; Douglas S Scherr; Christian Seitz; Karim Bensalah; Eckart Breinl; Eugene K Cha; Thomas F Chromecki; Gerhard Donner; Alon Z Weizer; Shahrokh F Shariat
Prognostic value of extranodal extension and other lymph node parameters in patients with upper tract urothelial carcinoma.
The Journal of urology 2012;187(3):845-51.
2012: Christopher E Barbieri; Eugene K Cha; Thomas F Chromecki; Allison Dunning; Pierre I Karakiewicz; Yair Lotan; Madhu Mazumdar; Douglas S Scherr; Maxine Sun; Robert S Svatek; Shahrokh F Shariat
Decision curve analysis assessing the clinical benefit of NMP22 in the detection of bladder cancer: secondary analysis of a prospective trial.
BJU international 2012;109(5):685-90.
2012: Firas Abdollah; Orchidee Djahangirian; Claudio Jeldres; Francesco Montorsi; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Rodolphe Thuret; Zhe Tian; Pierre I Karakiewicz
Survival after radical cystectomy of non-bilharzial squamous cell carcinoma vs urothelial carcinoma: a competing-risks analysis.
BJU international 2012;109(4):564-9.
2012: Jennifer E Reifsnyder; Shahrokh F Shariat; Benjamin Shin; Joseph J Del Pizzo; James Dipietro; Casey K Ng; Ranjith Ramasamy; Douglas S Scherr
Laparoscopic and open partial nephrectomy: complication comparison using the Clavien system.
JSLS : Journal of the Society of Laparoendoscopic Surgeons / Society of Laparoendoscopic Surgeons 2012;16(1):38-44.
2012: David J DeGraff; Henry F Frierson; Mary K Herrick; Justin M Cates; Sam S Chang; Peter E Clark; Michael S Cookson; Victoria L Robinson; Shahrokh F Shariat; Mark E Smolkin; Gary D Steinberg; Dan Theodorescu; Xue-Ru Wu; Hironobu Yamashita; Xiuping Yu; Robert J Matusik
Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferation.
PloS one 2012;7(5):e36669.
2012: Bobby B Najari; Michael Rink; Shahrokh F Shariat; Markus Graefen; Felix K Chun
Does low-risk prostate cancer detection change with repeat biopsies?
European urology 2012;61(1):230-1.
2012: Eugene K Cha; Paul J Christos; Joerg Hennenlotter; Thomas Martini; Christine Mian; Armin Pycha; Christian Schwentner; Shahrokh F Shariat; Arnulf Stenzl; Lenuta-Ancuta Tirsar; Bernd J Schmitz-Dräger
Immunocytology is a strong predictor of bladder cancer presence in patients with painless hematuria: a multicentre study.
European urology 2012;61(1):185-92.
2012: Michael Rink; Shahrokh F Shariat
Can we apply nomograms derived in the United States to European patients? Yes, we can!
European urology 2012;61(1):65-6.
2011: Nagireddy Putluri; Vasanta Putluri; Theodore R Sana; Shahrokh F Shariat; Huidong Shi; Ali Shojaie; Gabriel Sica; Daniel J Brat; Charles Butler; Steven M Fischer; Yair Lotan; George Michailidis; Srilatha Nalluri; Ganesh S Palapattu; Katrin Panzitt; Christopher T Tallman; Martha K Terris; Gagan Singh Thangjam; Shaiju K Vareed; Vihas T Vasu; Alon Z Weizer; Arun Sreekumar
Metabolomic profiling reveals potential markers and bioprocesses altered in bladder cancer progression.
Cancer research 2011;71(24):7376-86.
2011: Firas Abdollah; Alberto Briganti; Orchidee Djahangirian; Francesco Montorsi; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Rodolphe Thuret; Zhe Tian; Pierre I Karakiewicz
Head-to-head comparison of three commonly used preoperative tools for prediction of lymph node invasion at radical prostatectomy.
Urology 2011;78(6):1363-7.
2011: M Rink; B Robinson; D S Scherr; K Bensalah; F K H Chun; M Fisch; Pierre I Karakiewicz; R K Lee; V Margulis; M Sun; Shahrokh F Shariat
Tissue-based molecular markers for renal cell carcinoma.
Minerva urologica e nefrologica = The Italian journal of urology and nephrology 2011;63(4):293-308.
2011: Maxine Sun; Zhe Tian; Quoc-Dien Trinh; Hugues Widmer; Kevin Zorn; Firas Abdollah; Marco Bianchi; Claudio Jeldres; Mani Menon; Francesco Montorsi; Paul Perrotte; Shahrokh F Shariat; Pierre I Karakiewicz
A stage-for-stage and grade-for-grade analysis of cancer-specific mortality rates in renal cell carcinoma according to age: a competing-risks regression analysis.
European urology 2011;60(6):1152-9.
2011: Firas Abdollah; Alberto Briganti; Umberto Capitanio; Andrea Gallina; Francesco Montorsi; Paul Perrotte; Patrizio Rigatti; Andrea Salonia; Jan Schmitges; Shahrokh F Shariat; Nazareno Suardi; Maxine Sun; Rodolphe Thuret; Pierre I Karakiewicz
Critical assessment of the European Association of Urology guideline indications for pelvic lymph node dissection at radical prostatectomy.
BJU international 2011;108(11):1769-75.
2011: Richard Lee; Casey K Ng; Anna Borkina; Kevin F Brumit; Robert Guimento; Shahrokh F Shariat; Douglas S Scherr
The economics of robotic cystectomy: cost comparison of open versus robotic cystectomy.
BJU international 2011;108(11):1886-92.
2011: Shahrokh F Shariat; Christopher E Barbieri; Thomas F Chromecki; Zoran Culig; Julia Hoefer; Pierre I Karakiewicz; Francesco Montorsi; Claus G Roehrborn; Douglas S Scherr; Ilaria T Cavarretta
Soluble gp130 regulates prostate cancer invasion and progression in an interleukin-6 dependent and independent manner.
The Journal of urology 2011;186(5):2107-14.
2011: Quoc-Dien Trinh; Marco Bianchi; Markus Graefen; Claudio Jeldres; Mani Menon; James O Peabody; Paul Perrotte; Jesse Sammon; Jan Schmitges; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Zhe Tian; Pierre I Karakiewicz
Radical prostatectomy at academic versus nonacademic institutions: a population based analysis.
The Journal of urology 2011;186(5):1849-54.
2011: Jay D Raman; Mesut Remzi; Marco Roscigno; Arthur I Sagalowsky; Douglas S Scherr; Shahrokh F Shariat; Matthias Waldert; Alon Z Weizer; Jeffery C Wheat; Christopher G Wood; Christian Bolenz; Pierre I Karakiewicz; Yair Lotan; Vitaly Margulis; Francesco Montorsi; Casey K Ng
Does preoperative symptom classification impact prognosis in patients with clinically localized upper-tract urothelial carcinoma managed by radical nephroureterectomy?
Urologic oncology 2011;29(6):716-23.
2011: Marco Roscigno; Shahrokh F Shariat; Hendrik Van Poppel; Maurizio Brausi; Axel Heidenreich; Yair Lotan; Vitaly Margulis; Richard Zigeuner
Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer.
European urology 2011;60(4):776-83.
2011: Maxine Sun; Richard Zigeuner; Christopher Cheng; Vincenzo Ficarra; Masaru Murai; Stéphane Oudard; Allan J Pantuck; Shahrokh F Shariat; Pierre I Karakiewicz
Prognostic factors and predictive models in renal cell carcinoma: a contemporary review.
European urology 2011;60(4):644-61.
2011: Carmen Jerónimo; William G Nelson; Patrick J Bastian; Anders Bjartell; Giuseppina M Carbone; James W F Catto; Susan J Clark; Rui Henrique; Shahrokh F Shariat
Epigenetics in prostate cancer: biologic and clinical relevance.
European urology 2011;60(4):753-66.
2011: Maxine Sun; Zhe Tian; Firas Abdollah; Lars Budaüs; Markus Greafen; Rupinder Johal; Daniel Liberman; Francesco Montorsi; Monica Morgan; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Pierre I Karakiewicz
Trends of retroperitoneal lymphadenectomy use in patients with nonseminomatous germ cell tumor of the testis: a population-based study.
Annals of surgical oncology 2011;18(10):2997-3004.
2011: Kazumasa Matsumoto; Francesco Montorsi; Casey Ng; Giacomo Novara; Jay D Raman; Mesut Remzi; Joaquin Carballido Rodriguez; Marco Roscigno; Christian Seitz; Karim Bensalah; Christian Bolenz; Vincenzo Ficarra; Hans-Martin Fritsche; Amit Gupta; Masatsugu Iwamura; Pierre I Karakiewicz; Wassim Kassouf; Eiji Kikuchi; Theresa Koppie; Vitaly Margulis; Guido Martignoni; Stefan Tritschler; Thomas J Walton; Alon Z Weizer; Christopher G Wood; Richard Zigeuner; Shahrokh F Shariat
Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international study.
BJU international 2011;108(8 Pt 2):E304-9.
2011: Firas Abdollah; Francesco Montorsi; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Rodolphe Thuret; Pierre I Karakiewicz
Mortality and morbidity after cytoreductive nephrectomy for metastatic renal cell carcinoma: a population-based study.
Annals of surgical oncology 2011;18(10):2988-96.
2011: Ramy F Youssef; Richard Zigeuner; Christian Bolenz; Charles C Guo; Wareef Kabbani; Wassim Kassouf; Eiji Kikuchi; Cord Langner; Yair Lotan; Francesco Montorsi; Jay D Raman; Mesut Remzi; Marco Roscigno; Arthur I Sagalowsky; Shahrokh F Shariat; Alon Z Weizer; Christopher G Wood; Vitaly Margulis
Upper urinary tract urothelial carcinoma with loco-regional nodal metastases: insights from the Upper Tract Urothelial Carcinoma Collaboration.
BJU international 2011;108(8):1286-91.
2011: Maxine Sun; Rodolphe Thuret; Zhe Tian; Al'a Abdo; Firas Abdollah; Daniel Liberman; Francesco Montorsi; Paul Perrotte; Shahrokh F Shariat; Pierre I Karakiewicz
Racial disparities and socioeconomic status in men diagnosed with testicular germ cell tumors: a survival analysis.
Cancer 2011;117(18):4277-85.
2011: Sultan S Alkhateeb; Sas Bar-Moshe; Peter J Bostrom; Neil Fleshner; Sally Hanna; Michael Jewett; David M Kakiashvili; Mischel Neill; Michel Petein; Bas Van Rhijn; Sandrine Rorive; Thierry Roumeguere; Claude Schulman; Shahrokh F Shariat; Alexandre R Zlotta
Long-term prognostic value of the combination of EORTC risk group calculator and molecular markers in non-muscle-invasive bladder cancer patients treated with intravesical Bacille Calmette-Guérin.
Urology annals 2011;3(3):119-26.
2011: Richard Lee; Bilal Chughtai; Michael Herman; Shahrokh F Shariat; Douglas S Scherr
Cost-analysis comparison of robot-assisted laparoscopic radical cystectomy (RC) vs open RC.
BJU international 2011;108(6 Pt 2):976-83.
2011: Firas Abdollah; Orchidee Djahangirian; Markus Graefen; Claudio Jeldres; Francesco Montorsi; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Rodolphe Thuret; Pierre I Karakiewicz
Hospital and surgical caseload are predictors of comprehensive surgical treatment for bladder cancer: a population based study.
The Journal of urology 2011;186(3):824-8.
2011: Kazuhito Matsushita; Douglas S Scherr; Maxine Sun; Shiro Baba; Eugene K Cha; Thomas F Chromecki; Harun Fajkovic; Pierre I Karakiewicz; Kazumasa Matsumoto; Shahrokh F Shariat
Immunohistochemical biomarkers for bladder cancer prognosis.
International journal of urology : official journal of the Japanese Urological Association 2011;18(9):616-29.
2011: Thomas F Chromecki; Shahrokh F Shariat; Eugene K Cha
Stage pT0 after radical cystectomy: are all patients equal?
European urology 2011;60(3):603-4.
2011: Firas Abdollah; Orchidee Djahangirian; Claudio Jeldres; Francesco Montorsi; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Rodolphe Thuret; Zhe Tian; Pierre I Karakiewicz
Surgical caseload is an important determinant of continent urinary diversion rate at radical cystectomy: a population-based study.
Annals of surgical oncology 2011;18(9):2680-7.
2011: Jamie Messer; Casey K Ng; Stephen A Boorjian; James C Brien; Scott E Eggener; Michael P Herman; Yair Lotan; Steven M Lucas; Douglas S Scherr; Benjamin Scoll; Shahrokh F Shariat; Gary Steinberg; John D Terrell; Robert G Uzzo; Mark Wille; Jay D Raman
Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma.
BJU international 2011;108(5):701-5.
2011: Youness Ahallal; Daher C Chade; Vincent Laudone; Clarisse Mazzola; Victor E Reuter; Jaspreet S Sandhu; Shahrokh F Shariat; Karim Touijer; Bertrand D Guillonneau
Pilot study of salvage laparoscopic prostatectomy for the treatment of recurrent prostate cancer.
BJU international 2011;108(5):724-8.
2011: Lars Budäus; Markus Graefen; Alexander Haese; Hendrik Isbarn; Rupinder Johal; Firas Abdollah; Giovanni Lughezzani; Francesco Montorsi; Monica Morgan; Paul Perrotte; Shahrokh F Shariat; Maxine Sun; Rodolphe Thuret; Kevin C Zorn; Pierre I Karakiewicz
The impact of surgical experience on total hospital charges for minimally invasive prostatectomy: a population-based study.
BJU international 2011;108(6):888-93.
2011: Guru Sonpavde; Robert S Svatek; Derya Tilki; Eila Skinner; Gilad E Amiel; Patrick J Bastian; Colin P Dinney; Vincenzo Ficarra; Yves Fradet; Hans-Martin Fritsche; Jonathan I Izawa; Pierre I Karakiewicz; Wassim Kassouf; Myrna M Khan; Richard Lee; Seth P Lerner; Yair Lotan; Giacomo Novara; Shahrokh F Shariat
Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomy.
BJU international 2011;108(5):687-92.
2011: Rodolphe Thuret; Firas Abdollah; Jacques Guiter; François Iborra; Jean-Jacques Patard; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Pierre I Karakiewicz
Conditional survival predictions after surgery for patients with penile carcinoma.
Cancer 2011;117(16):3723-30.
2011: Axel S Merseburger; Shahrokh F Shariat
Urothelial carcinoma.
World journal of urology 2011;29(4):405-7.
2011: Thomas F Chromecki; Pierre I Karakiewicz; Giacomo Novara; Mesut Remzi; Douglas S Scherr; Shahrokh F Shariat; Grégory Verhoest; Karim Bensalah; Eugene K Cha
Prognostic factors for upper urinary tract urothelial carcinoma.
Nature reviews. Urology 2011;8(8):440-7.
2011: Grégory Verhoest; Thomas F Chromecki; Vitaly Margulis; Giacomo Novara; Jay D Raman; Mesut Remzi; Morgan Rouprêt; Douglas S Scherr; Christian Seitz; Shahrokh F Shariat; Karim Bensalah
Predictive factors of recurrence and survival of upper tract urothelial carcinomas.
World journal of urology 2011;29(4):495-501.
2011: Harun Fajkovic; Joshua A Halpern; Pierre I Karakiewicz; Axel S Merseburger; Atessa Bahadori; Eckart Breinl; Eugene K Cha; Thomas F Chromecki; Shahrokh F Shariat
Impact of gender on bladder cancer incidence, staging, and prognosis.
World journal of urology 2011;29(4):457-63.
2011: Firas Abdollah; Claudio Jeldres; Al'a Abdo; Francesco Montorsi; Monica Morgan; Paul Perrotte; Shahrokh F Shariat; Maxine Sun; Rodolphe Thuret; Pierre I Karakiewicz
The effect of marital status on stage and survival of prostate cancer patients treated with radical prostatectomy: a population-based study.
Cancer causes & control : CCC 2011;22(8):1085-95.
2011: Maximilian Burger; Thomas F Chromecki; Vincenzo Ficarra; Hans-Martin Fritsche; Wassim Kassouf; Juan Ignacio Martinez-Salamanca; Kazumasa Matsumoto; Armin Pycha; Christian Seitz; Shahrokh F Shariat; Stefan Tritschler; Thomas J Walton; Giacomo Novara
No overt influence of lymphadenectomy on cancer-specific survival in organ-confined versus locally advanced upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy: a retrospective international, multi-institutional study.
World journal of urology 2011;29(4):465-72.
2011: Thomas F Chromecki; Felix K Chun; Behfar Ehdaie; Hans-Martin Fritsche; Pierre I Karakiewicz; Wassim Kassouf; Richard K Lee; Juan I Martínez Salamanca; Kazumasa Matsumoto; Casey Ng; Giacomo Novara; Karl Pummer; Armin Pycha; Jay D Raman; Douglas S Scherr; Christian Seitz; Patrick J Bastian; Eugene K Cha; Thomas J Walton; Richard Zigeuner; Shahrokh F Shariat
Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy.
World journal of urology 2011;29(4):473-80.
2011: Daher C Chade; Angel M Cronin; Marcos Dall'Oglio; Michael L Blute; Alberto Briganti; Martin E Gleave; Guilherme Godoy; Antonio Hurtado-coll; Steven Joniau; R Jeffrey Karnes; Francesco Montorsi; Caroline J Savage; Peter T Scardino; Shahrokh F Shariat; Miguel Srougi; Henk G van der Poel; Hendrik Van Poppel; James A Eastham
Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration.
European urology 2011;60(2):205-10.
2011: Wolfgang Otto; Armin Pycha; Christian Seitz; Shahrokh F Shariat; Stefan Tritschler; Thomas J Walton; Shiro Baba; Patrick J Bastian; Maximilian Burger; Vincenzo Ficarra; Hans-Martin Fritsche; Amit Gupta; Pierre I Karakiewicz; Wassim Kassouf; Guido Martignoni; Juan I Martínez Salamanca; Kazumasa Matsumoto; Giacomo Novara
Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients.
World journal of urology 2011;29(4):487-94.
2011: John P Sfakianos; Shahrokh F Shariat; Ricardo Lima Favaretto; Jorge Rioja; Harry W Herr
Impact of smoking on outcomes after intravesical bacillus Calmette-Guérin therapy for urothelial carcinoma not invading muscle of the bladder.
BJU international 2011;108(4):526-30.
2011: Thomas J Walton; Stephen A Thomas; Stefan Tritschler; Walter Artibani; Patrick J Bastian; Maximilian Burger; Vincenzo Ficarra; Hans-Martin Fritsche; Pierre I Karakiewicz; Wassim Kassouf; Juan I Martínez Salamanca; Kazumasa Matsumoto; Giacomo Novara; Christian Seitz; Shahrokh F Shariat
Oncological outcomes after laparoscopic and open radical nephroureterectomy: results from an international cohort.
BJU international 2011;108(3):406-12.
2011: David S Yee; Angel M Cronin; William T Lowrance; Alexandra C Maschino; Caroline J Savage; Peter T Scardino; Shahrokh F Shariat; James A Eastham
Prognostic significance of lymphovascular invasion in radical prostatectomy specimens.
BJU international 2011;108(4):502-7.
2011: Shahrokh F Shariat; Stefan Tritschler; Thomas J Walton; Wolfgang Otto; Armin Pycha; Christian Seitz; Shiro Baba; Patrick J Bastian; Ricardo L Favaretto; Vincenzo Ficarra; Hans-Martin Fritsche; Amit Gupta; Pierre I Karakiewicz; Wassim Kassouf; Juan I Martínez Salamanca; Kazumasa Matsumoto; Kazuhito Matsushita; Giacomo Novara
Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma.
World journal of urology 2011;29(4):481-6.
2011: Shahrokh F Shariat; Maxine Sun; Thomas F Chromecki; Pierre I Karakiewicz; Richard K Lee; Giovanni Lughezzani; Michael J Marberger; Mesut Remzi; Caroline Savage; Douglas S Scherr; Andrew J Vickers
Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with nonmuscle-invasive bladder cancer and negative cytology: a decision-curve analysis.
Cancer 2011;117(13):2892-7.
2011: Behfar Ehdaie; Pierre I Karakiewicz; Richard K Lee; Yair Lotan; William T Lowrance; Vitaly Margulis; Casey Ng; Giacomo Novara; Jay D Raman; Douglas Scherr; Thomas F Chromecki; Shahrokh F Shariat
Obesity adversely impacts disease specific outcomes in patients with upper tract urothelial carcinoma.
The Journal of urology 2011;186(1):66-72.
2011: Ramy Youssef; Ahmed Mosbah; Shahrokh F Shariat; Hassan Abol-Enein; Mohamed Ghoniem; Wareef Kabbani; Payal Kapur; Yair Lotan
Bilharzial vs non-bilharzial related bladder cancer: pathological characteristics and value of cyclooxygenase-2 expression.
BJU international 2011;108(1):31-7.
2011: Carmen Mir; Hiroshi Miyamoto; Juan Morote; Shahrokh F Shariat; Sean Skeldon; Rati Vajpeyi; Theodorus H van der Kwast; Bas W G van Rhijn; Jorge Yao; Sultan Alkhateeb; Raheela Ashfaq; Peter Bostrom; Andrew Evans; Neil Fleshner; Sally Hanna; Michael Jewett; Cynthia Kuk; Yair Lotan; Ed Messing; Alexandre R Zlotta
Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: a large multi-institutional study.
BJU international 2011;108(1):24-30.
2011: Shahrokh F Shariat; Axel Semjonow; Hans Lilja; Caroline Savage; Andrew J Vickers; Anders Bjartell
Tumor markers in prostate cancer I: blood-based markers.
Acta oncologica (Stockholm, Sweden) 2011;50 Suppl 1():61-75.
2011: Firas Abdollah; Maxine Sun; Shahrokh F Shariat; Jan Schmitges; Orchidee Djahangirian; Zhe Tian; Claudio Jeldres; Paul Perrotte; Francesco Montorsi; Pierre I Karakiewicz
The importance of pelvic lymph node dissection in the elderly population: implications for interpreting the 2010 National Comprehensive Cancer Network practice guidelines for bladder cancer treatment.
The Journal of urology 2011;185(6):2078-84.
2011: Alexandre R Zlotta; Thierry Roumeguere; Cynthia Kuk; Sultan Alkhateeb; Sandrine Rorive; Anne Lemy; Theodorus H van der Kwast; Neil E Fleshner; Michael A S Jewett; Antonio Finelli; Claude Schulman; Yair Lotan; Shahrokh F Shariat; Joelle Nortier
Select screening in a specific high-risk population of patients suggests a stage migration toward detection of non-muscle-invasive bladder cancer.
European urology 2011;59(6):1026-31.
2011: Cenk Gurbuz; Ramy F Youssef; Shahrokh F Shariat; Yair Lotan; Christopher G Wood; Arthur I Sagalowsky; Richard Zigeuner; Eiji Kikuchi; Alon Z Weizer; Jay D Raman; Mesut Remzi; Marco Roscigno; Francesco Montorsi; Christian Bolenz; Wassim Kassouf; Vitaly Margulis
The impact of previous ureteroscopic tumor ablation on oncologic outcomes after radical nephrouretectomy for upper urinary tract urothelial carcinoma.
Journal of endourology / Endourological Society 2011;25(5):775-9.
2011: Guru Sonpavde; Myrna M Khan; Robert S Svatek; Richard Lee; Giacomo Novara; Derya Tilki; Seth P Lerner; Gilad E Amiel; Eila Skinner; Pierre I Karakiewicz; Patrick J Bastian; Wassim Kassouf; Hans-Martin Fritsche; Jonathan I Izawa; Douglas S Scherr; Vincenzo Ficarra; Colin P Dinney; Yair Lotan; Yves Fradet; Shahrokh F Shariat
Prognostic risk stratification of pathological stage T3N0 bladder cancer after radical cystectomy.
The Journal of urology 2011;185(4):1216-21.
2011: Eugene K Cha; Shahrokh F Shariat
The use of 5α-reductase inhibitors for the prevention and treatment of prostate cancer.
European urology 2011;59(4):515-7.
2011: Ramy F Youssef; Shahrokh F Shariat; Yair Lotan; Christopher G Wood; Arthur I Sagalowsky; Richard Zigeuner; Cord Langner; Francesco Montorsi; Christian Bolenz; Vitaly Margulis
Prognostic effect of urinary bladder carcinoma in situ on clinical outcome of subsequent upper tract urothelial carcinoma.
Urology 2011;77(4):861-6.
2011: Daniel Liberman; Giovanni Lughezzani; Maxine Sun; Ahmed Alasker; Rodolphe Thuret; Firas Abdollah; Lars Budaus; Hugues Widmer; Markus Graefen; Francesco Montorsi; Shahrokh F Shariat; Paul Perrotte; Pierre I Karakiewicz
Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder.
Urology 2011;77(3):660-6.
2011: Ramy F Youssef; Shahrokh F Shariat; Payal Kapur; Wareef Kabbani; Ahmed Mosbah; Hassan Abol-Enein; Mohamed Ghoniem; Yair Lotan
Prognostic value of cyclooxygenase-2 expression in squamous cell carcinoma of the bladder.
The Journal of urology 2011;185(3):1112-7.
2011: Robert S Svatek; Shahrokh F Shariat; Giacomo Novara; Eila C Skinner; Yves Fradet; Patrick J Bastian; Ashish M Kamat; Wassim Kassouf; Pierre I Karakiewicz; Hans-Martin Fritsche; Jonathan I Izawa; Derya Tilki; Vincenzo Ficarra; Bjoern G Volkmer; Hendrik Isbarn; Colin P Dinney
Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort.
BJU international 2011;107(6):898-904.
2011: Ramy F Youssef; Shahrokh F Shariat; Payal Kapur; Wareef Kabbani; Tarek Ghoneim; Ellen King; Amber Cockburn; Ahmed Mosbah; Hassan Abol-Enein; Mohamed Ghoneim; Yair Lotan
Expression of cell cycle-related molecular markers in patients treated with radical cystectomy for squamous cell carcinoma of the bladder.
Human pathology 2011;42(3):347-55.
2011: Lars Budäus; Maxine Sun; Firas Abdollah; Kevin C Zorn; Monica Morgan; Rupinder Johal; Daniel Liberman; Rodolphe Thuret; Hendrik Isbarn; Georg Salomon; Alexander Haese; Francesco Montorsi; Shahrokh F Shariat; Paul Perrotte; Markus Graefen; Pierre I Karakiewicz
Impact of surgical experience on in-hospital complication rates in patients undergoing minimally invasive prostatectomy: a population-based study.
Annals of surgical oncology 2011;18(3):839-47.
2011: Daniel Liberman; Ahmed Alasker; Maxine Sun; Salima Ismail; Giovanni Lughezzani; Claudio Jeldres; Lars Budaus; Rodolphe Thuret; Shahrokh F Shariat; Hugues Widmer; Paul Perrotte; Markus Graefen; Francesco Montorsi; Pierre I Karakiewicz
Radical cystectomy for patients with pT4 urothelial carcinoma in a large population-based study.
BJU international 2011;107(6):905-11.
2011: Guru Sonpavde; Myrna M Khan; Seth P Lerner; Robert S Svatek; Giacomo Novara; Pierre I Karakiewicz; Eila Skinner; Derya Tilki; Wassim Kassouf; Yves Fradet; Colin P Dinney; Hans-Martin Fritsche; Jonathan I Izawa; Patrick J Bastian; Vincenzo Ficarra; Mark P Schoenberg; Arthur I Sagalowsky; Yair Lotan; Shahrokh F Shariat
Disease-free survival at 2 or 3 years correlates with 5-year overall survival of patients undergoing radical cystectomy for muscle invasive bladder cancer.
The Journal of urology 2011;185(2):456-61.
2011: Rodolphe Thuret; Maxine Sun; Firas Abdollah; Lars Budaus; Giovanni Lughezzani; Daniel Liberman; Monica Morgan; Rupinder Johal; Claudio Jeldres; Mathieu Latour; Shahrokh F Shariat; François Iborra; Jacques Guiter; Jean-Jacques Patard; Paul Perrotte; Pierre I Karakiewicz
Tumor grade improves the prognostic ability of American Joint Committee on Cancer stage in patients with penile carcinoma.
The Journal of urology 2011;185(2):501-7.
2011: Rodolphe Thuret; Maxine Sun; Giovanni Lughezzani; Lars Budaus; Daniel Liberman; Firas Abdollah; Monica Morgan; Rupinder Johal; Claudio Jeldres; Mathieu Latour; Shahrokh F Shariat; François Iborra; Jacques Guiter; Jean-Jacques Patard; Paul Perrotte; Pierre I Karakiewicz
A contemporary population-based assessment of the rate of lymph node dissection for penile carcinoma.
Annals of surgical oncology 2011;18(2):439-46.
2011: Philipp Nuhn; Eila Skinner; Guru Sonpavde; Robert S Svatek; Derya Tilki; Patrick J Bastian; Colin P Dinney; Vincenzo Ficarra; Yves Fradet; Hans-Martin Fritsche; Hendrik Isbarn; Jonathan I Izawa; Pierre I Karakiewicz; Wassim Kassouf; Francesco Montorsi; Stefan C Müller; Giacomo Novara; Shahrokh F Shariat
Concomitant carcinoma in situ in cystectomy specimens is not associated with clinical outcomes after surgery.
Urologia internationalis 2011;87(1):42-8.
2011: C R E Mazzola; T Ghoneim; Shahrokh F Shariat
[Emerging biomarkers for the diagnosis, staging and prognosis of prostate cancer].
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie 2011;21(1):1-10.
2011: Maxine Sun; Rodolphe Thuret; Firas Abdollah; Giovanni Lughezzani; Jan Schmitges; Zhe Tian; Shahrokh F Shariat; Francesco Montorsi; Jean-Jacques Patard; Paul Perrotte; Pierre I Karakiewicz
Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis.
European urology 2011;59(1):135-41.
2011: Firas Abdollah; Maxine Sun; Rodolphe Thuret; Claudio Jeldres; Zhe Tian; Alberto Briganti; Shahrokh F Shariat; Paul Perrotte; Patrizio Rigatti; Francesco Montorsi; Pierre I Karakiewicz
A competing-risks analysis of survival after alternative treatment modalities for prostate cancer patients: 1988-2006.
European urology 2011;59(1):88-95.
2011: Giovanni Lughezzani; Maxine Sun; Shahrokh F Shariat; Lars Budäus; Rodolphe Thuret; Claudio Jeldres; Daniel Liberman; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
A population-based competing-risks analysis of the survival of patients treated with radical cystectomy for bladder cancer.
Cancer 2011;117(1):103-9.
2011: Casey K Ng; Shahrokh F Shariat; Steven M Lucas; Aditya Bagrodia; Yair Lotan; Douglas S Scherr; Jay D Raman
Does the presence of hydronephrosis on preoperative axial CT imaging predict worse outcomes for patients undergoing nephroureterectomy for upper-tract urothelial carcinoma?
Urologic oncology 2011;29(1):27-32.
2010: Maxine Sun; Al'a Abdo; Firas Abdollah; Jan Schmitges; Rodolphe Thuret; Claudio Jeldres; Shahrokh F Shariat; Paul Perrotte; Pierre I Karakiewicz
Management of upper urinary tract urothelial carcinoma.
Expert review of anticancer therapy 2010;10(12):1955-65.
2010: Lars Budäus; Firas Abdollah; Maxine Sun; Monica Morgan; Rupinder Johal; Rodolphe Thuret; Kevin C Zorn; Hendrik Isbarn; Shahrokh F Shariat; Francesco Montorsi; Paul Perrotte; Markus Graefen; Pierre I Karakiewicz
Annual surgical caseload and open radical prostatectomy outcomes: improving temporal trends.
The Journal of urology 2010;184(6):2285-90.
2010: fianceeyi chun; Jonathan I Epstein; Vincenzo Ficarra; Stephen J Freedland; Rodolfo Montironi; Francesco Montorsi; Shahrokh F Shariat; Fritz H Schröder; Vincenzo Scattoni
Optimizing performance and interpretation of prostate biopsy: a critical analysis of the literature.
European urology 2010;58(6):851-64.
2010: Christian Seitz; Amit Gupta; Shahrokh F Shariat; Kazumasa Matsumoto; Wassim Kassouf; Thomas J Walton; Hans-Martin Fritsche; Wolfgang Otto; Stefan Tritschler; Patrick J Bastian; Joaquin Carballido; Vincenzo Ficarra; Pierre I Karakiewicz; Walter Artibani; Guido Mazzoleni; Giacomo Novara
Association of tumor necrosis with pathological features and clinical outcome in 754 patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma: an international validation study.
The Journal of urology 2010;184(5):1895-900.
2010: Giovanni Lughezzani; Alberto Briganti; Pierre I Karakiewicz; Michael W Kattan; Francesco Montorsi; Shahrokh F Shariat; Andrew J Vickers
Predictive and prognostic models in radical prostatectomy candidates: a critical analysis of the literature.
European urology 2010;58(5):687-700.
2010: Ricardo L Favaretto; Shahrokh F Shariat; Daher C Chade; Guilherme Godoy; Matthew Kaag; Angel M Cronin; Bernard H Bochner; Jonathan Coleman; Guido Dalbagni
Comparison between laparoscopic and open radical nephroureterectomy in a contemporary group of patients: are recurrence and disease-specific survival associated with surgical technique?
European urology 2010;58(5):645-51.
2010: Maxime Crépel; Claudio Jeldres; Maxine Sun; Giovanni Lughezzani; Hendrik Isbarn; Ahmed Alasker; umberto capitanio; Shahrokh F Shariat; Philippe Arjane; Hugues Widmer; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma.
Urology 2010;76(4):883-8.
2010: Ricardo L Favaretto; Shahrokh F Shariat; Daher C Chade; Guilherme Godoy; Ari Adamy; Matthew Kaag; Bernard H Bochner; Jonathan Coleman; Guido Dalbagni
The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center.
European urology 2010;58(4):574-80.
2010: Christian Bolenz; Shahrokh F Shariat; Pierre I Karakiewicz; Raheela Ashfaq; Richard Ho; Arthur I Sagalowsky; Yair Lotan
Human epidermal growth factor receptor 2 expression status provides independent prognostic information in patients with urothelial carcinoma of the urinary bladder.
BJU international 2010;106(8):1216-22.
2010: C E Barbieri; Y Lotan; R K Lee; Guru Sonpavde; Pierre I Karakiewicz; B Robinson; Douglas Scherr; Shahrokh F Shariat
Tissue-based molecular markers for bladder cancer.
Minerva urologica e nefrologica = The Italian journal of urology and nephrology 2010;62(3):241-58.
2010: Robert S Svatek; Shahrokh F Shariat; Robert E Lasky; Eila C Skinner; Giacomo Novara; Seth P Lerner; Yves Fradet; Patrick J Bastian; Wassim Kassouf; Pierre I Karakiewicz; Hans-Martin Fritsche; Stefan C Müller; Jonathan I Izawa; Vincenzo Ficarra; Arthur I Sagalowsky; Mark P Schoenberg; Arlene Siefker-Radtke; Randall E Millikan; Colin P N Dinney
The effectiveness of off-protocol adjuvant chemotherapy for patients with urothelial carcinoma of the urinary bladder.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(17):4461-7.
2010: Derya Tilki; Robert S Svatek; Giacomo Novara; Michael Seitz; Guilherme Godoy; Pierre I Karakiewicz; Wassim Kassouf; Yves Fradet; Hans-Martin Fritsche; Guru Sonpavde; Jonathan I Izawa; Vincenzo Ficarra; Seth P Lerner; Mark P Schoenberg; Christian G Stief; Colin P Dinney; Eila Skinner; Yair Lotan; Arthur I Sagalowsky; Oliver Reich; Shahrokh F Shariat
Stage pT0 at radical cystectomy confers improved survival: an international study of 4,430 patients.
The Journal of urology 2010;184(3):888-94.
2010: Maxine Sun; Shahrokh F Shariat; Pierre I Karakiewicz
Factors affecting outcome in renal cell carcinoma.
Current opinion in urology 2010;20(5):355-60.
2010: Claudio Jeldres; Maxine Sun; Giovanni Lughezzani; Hendrik Isbarn; Shahrokh F Shariat; Hugues Widmer; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Highly predictive survival nomogram after upper urinary tract urothelial carcinoma.
Cancer 2010;116(16):3774-84.
2010: Derya Tilki; Robert S Svatek; Pierre I Karakiewicz; Giacomo Novara; Michael Seitz; Guru Sonpavde; Amit Gupta; Wassim Kassouf; Yves Fradet; Vincenzo Ficarra; Eila Skinner; Yair Lotan; Arthur I Sagalowsky; Christian G Stief; Oliver Reich; Shahrokh F Shariat
pT3 Substaging is a prognostic indicator for lymph node negative urothelial carcinoma of the bladder.
The Journal of urology 2010;184(2):470-4.
2010: Daher C Chade; Shahrokh F Shariat; Ari Adamy; Bernard H Bochner; S Machele Donat; Harry W Herr; Guido Dalbagni
Clinical outcome of primary versus secondary bladder carcinoma in situ.
The Journal of urology 2010;184(2):464-9.
2010: Vitaly Margulis; Ramy F Youssef; Pierre I Karakiewicz; Yair Lotan; Christopher G Wood; Richard Zigeuner; Eiji Kikuchi; Alon Z Weizer; Jay D Raman; Mesut Remzi; Marco Roscigno; Francesco Montorsi; Christian Bolenz; Wassim Kassouf; Shahrokh F Shariat
Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract.
The Journal of urology 2010;184(2):453-8.
2010: Dirk Zaak; Maximilian Burger; Wolfgang Otto; Patrick J Bastian; Stefan Denzinger; Christian G Stief; Hannes Buchner; Arndt Hartmann; Wolf F Wieland; Shahrokh F Shariat; Hans-Martin Fritsche
Predicting individual outcomes after radical cystectomy: an external validation of current nomograms.
BJU international 2010;106(3):342-8.
2010: Yair Lotan; Shahrokh F Shariat; Bernd J Schmitz-Dräger; Marta Sanchez-Carbayo; Feliksas Jankevicius; Marco Racioppi; Sarah J P Minner; Brigitte Stöhr; Pier Francesco Bassi; H Barton Grossman
Considerations on implementing diagnostic markers into clinical decision making in bladder cancer.
Urologic oncology 2010;28(4):441-8.
2010: Shahrokh F Shariat; Yair Lotan; Andrew J Vickers; Pierre I Karakiewicz; Bernd J Schmitz-Dräger; Peter J Goebell; Núria Malats
Statistical consideration for clinical biomarker research in bladder cancer.
Urologic oncology 2010;28(4):389-400.
2010: Daher C Chade; Shahrokh F Shariat; Guilherme Godoy; Caroline J Savage; Angel M Cronin; Bernard H Bochner; S Machele Donat; Harry W Herr; Guido Dalbagni
Clinical outcomes of primary bladder carcinoma in situ in a contemporary series.
The Journal of urology 2010;184(1):74-80.
2010: James C Brien; Shahrokh F Shariat; Michael P Herman; Casey K Ng; Douglas S Scherr; Benjamin Scoll; Robert G Uzzo; Mark Wille; Scott E Eggener; John D Terrell; Steven M Lucas; Yair Lotan; Stephen A Boorjian; Jay D Raman
Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma.
The Journal of urology 2010;184(1):69-73.
2010: Derya Tilki; Oliver Reich; Pierre I Karakiewicz; Giacomo Novara; Wassim Kassouf; Süleyman Ergün; Yves Fradet; Vincenzo Ficarra; Guru Sonpavde; Christian G Stief; Eila Skinner; Robert S Svatek; Yair Lotan; Arthur I Sagalowsky; Shahrokh F Shariat
Validation of the AJCC TNM substaging of pT2 bladder cancer: deep muscle invasion is associated with significantly worse outcome.
European urology 2010;58(1):112-7.
2010: Giacomo Novara; Robert S Svatek; Pierre I Karakiewicz; Eila Skinner; Vincenzo Ficarra; Yves Fradet; Yair Lotan; Hendrik Isbarn; Umberto Capitanio; Patrick J Bastian; Wassim Kassouf; Hans-Martin Fritsche; Jonathan I Izawa; Derya Tilki; Colin P Dinney; Seth P Lerner; Mark P Schoenberg; Bjoern G Volkmer; Arthur I Sagalowsky; Shahrokh F Shariat
Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients.
The Journal of urology 2010;183(6):2165-70.
2010: Giacomo Novara; Kazumasa Matsumoto; Wassim Kassouf; Thomas J Walton; Hans-Martin Fritsche; Patrick J Bastian; Juan I Martínez Salamanca; Christian Seitz; R John Lemberger; Maximilian Burger; Assaad El-Hakim; Shiro Baba; Guido Martignoni; Amit Gupta; Pierre I Karakiewicz; Vincenzo Ficarra; Shahrokh F Shariat
Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study.
European urology 2010;57(6):1064-71.
2010: Giovanni Lughezzani; Maxine Sun; Paul Perrotte; Shahrokh F Shariat; Claudio Jeldres; Lars Budaus; Ahmed Alasker; AJ Duclos; Hugues Widmer; Mathieu Latour; Giorgio Guazzoni; Francesco Montorsi; Pierre I Karakiewicz
Should bladder cuff excision remain the standard of care at nephroureterectomy in patients with urothelial carcinoma of the renal pelvis? A population-based study.
European urology 2010;57(6):956-62.
2010: Shahrokh F Shariat; Guilherme Godoy; Yair Lotan; Michael Droller; Pierre I Karakiewicz; Jay D Raman; Hendrik Isbarn; Alon Z Weizer; Mesut Remzi; Marco Roscigno; Eiji Kikuchi; Christian Bolenz; Karim Bensalah; Theresa Koppie; Wassim Kassouf; Jeffrey C Wheat; Richard Zigeuner; Cord Langner; Christopher G Wood; Vitaly Margulis
Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomy.
BJU international 2010;105(12):1672-7.
2010: Hendrik Isbarn; Jean-Jacques Patard; Giovanni Lughezzani; Nathalie Rioux-Leclercq; Maxime Crépel; Luca Cindolo; Alexandre de la Taille; Laurent Zini; Arnauld Villers; Shahrokh F Shariat; Roberto Bertini; Pierre I Karakiewicz
Limited prognostic value of tumor necrosis in patients with renal cell carcinoma.
Urology 2010;75(6):1378-84.
2010: Jay D Raman; Casey K Ng; Douglas S Scherr; Vitaly Margulis; Yair Lotan; Karim Bensalah; Jean-Jacques Patard; Eiji Kikuchi; Francesco Montorsi; Richard Zigeuner; Alon Z Weizer; Christian Bolenz; Theresa Koppie; Hendrik Isbarn; Claudio Jeldres; Wareef Kabbani; Mesut Remzi; Mathias Waldert; Christopher G Wood; Marco Roscigno; Mototsuga Oya; Cord Langner; J. Stuart Wolf, Jr.; Philipp Ströbel; Mario Fernández; Pierre Karakiewcz; Shahrokh F Shariat
Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy.
European urology 2010;57(6):1072-9.
2010: Shahrokh F Shariat; Daher C Chade; Pierre I Karakiewicz; Douglas S Scherr; Guido Dalbagni
Update on intravesical agents for non-muscle-invasive bladder cancer.
Immunotherapy 2010;2(3):381-92.
2010: Derya Tilki; Oliver Reich; Robert S Svatek; Pierre I Karakiewicz; Wassim Kassouf; Giacomo Novara; Vincenzo Ficarra; Daher C Chade; Hans-Martin Fritsche; Niklas Gerwens; Jonathan I Izawa; Seth P Lerner; Mark P Schoenberg; Christian G Stief; Eila Skinner; Yair Lotan; Arthur I Sagalowsky; Shahrokh F Shariat
Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients.
The Journal of urology 2010;183(5):1757-63.
2010: Shahrokh F Shariat; Ramy F Youssef; Amit Gupta; Daher C Chade; Pierre I Karakiewicz; Hendrik Isbarn; Claudio Jeldres; Arthur I Sagalowsky; Raheela Ashfaq; Yair Lotan
Association of angiogenesis related markers with bladder cancer outcomes and other molecular markers.
The Journal of urology 2010;183(5):1744-50.
2010: David S Yee; Shahrokh F Shariat; William T Lowrance; Joseph R Sterbis; Kinjal C Vora; Bernard H Bochner; S Machele Donat; Harry W Herr; Guido Dalbagni; Jaspreet S Sandhu
Impact of previous radiotherapy for prostate cancer on clinical outcomes of patients with bladder cancer.
The Journal of urology 2010;183(5):1751-6.
2010: Shahrokh F Shariat; Robert S Svatek; Derya Tilki; Eila Skinner; Pierre I Karakiewicz; Umberto Capitanio; Patrick J Bastian; Bjoern G Volkmer; Wassim Kassouf; Giacomo Novara; Hans-Martin Fritsche; Jonathan I Izawa; Vincenzo Ficarra; Seth P Lerner; Arthur I Sagalowsky; Mark P Schoenberg; Ashish M Kamat; Colin P Dinney; Yair Lotan; Michael J Marberger; Yves Fradet
International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy.
BJU international 2010;105(10):1402-12.
2010: Shahrokh F Shariat; Derya Tilki
Bladder cancer: nomogram aids clinical decision making after radical cystectomy.
Nature reviews. Urology 2010;7(4):182-4.
2010: Claudio Jeldres; Giovanni Lughezzani; Maxine Sun; Hendrik Isbarn; Shahrokh F Shariat; Lars Budaus; Jean-Baptiste Lattouf; Hugues Widmer; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Segmental ureterectomy can safely be performed in patients with transitional cell carcinoma of the ureter.
The Journal of urology 2010;183(4):1324-9.
2010: Richard Zigeuner; Shahrokh F Shariat; Vitaly Margulis; Pierre I Karakiewicz; Marco Roscigno; Alon Z Weizer; Eiji Kikuchi; Mesut Remzi; Jay D Raman; Christian Bolenz; Karim Bensalah; umberto capitanio; Theresa Koppie; Wassim Kassouf; Kanishka Sircar; Jean-Jacques Patard; Mario I Fernández; Christopher G Wood; Francesco Montorsi; Philipp Ströbel; Jeffery C Wheat; Andrea Haitel; Mototsugu Oya; Charles C Guo; Casey Ng; Daher C Chade; Arthur Sagalowsky; Cord Langner
Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract.
European urology 2010;57(4):575-81.
2010: Derya Tilki; Bernhard B Singer; Shahrokh F Shariat; Andreas Behrend; Malkanthi Fernando; Ster Irmak; Alexander Buchner; Andrea T Hooper; Christian G Stief; Oliver Reich; Süleyman Ergün
CEACAM1: a novel urinary marker for bladder cancer detection.
European urology 2010;57(4):648-54.
2010: Giovanni Lughezzani; Maxine Sun; Lars Budäus; Rodolphe Thuret; Shahrokh F Shariat; Paul Perrotte; Pierre I Karakiewicz
Effect of the number of biopsy cores on prostate cancer detection and staging.
Future oncology (London, England) 2010;6(3):381-90.
2010: Maxine Sun; Giovanni Lughezzani; Ahmed Alasker; Hendrik Isbarn; Claudio Jeldres; Shahrokh F Shariat; Lars Budäus; Jean-Baptiste Lattouf; Luc Valiquette; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Comparative study of inguinal hernia repair after radical prostatectomy, prostate biopsy, transurethral resection of the prostate or pelvic lymph node dissection.
The Journal of urology 2010;183(3):970-5.
2010: Giovanni Lughezzani; Maxine Sun; Paul Perrotte; Claudio Jeldres; Ahmed Alasker; Hendrik Isbarn; Lars Budäus; Shahrokh F Shariat; Giorgio Guazzoni; Francesco Montorsi; Pierre I Karakiewicz
The European Network for the Study of Adrenal Tumors staging system is prognostically superior to the international union against cancer-staging system: a North American validation.
European journal of cancer (Oxford, England : 1990) 2010;46(4):713-9.
2010: Matthias Waldert; Pierre I Karakiewicz; Jay D Raman; Mesut Remzi; Hendrik Isbarn; Yair Lotan; umberto capitanio; Karim Bensalah; Michael J Marberger; Shahrokh F Shariat
A delay in radical nephroureterectomy can lead to upstaging.
BJU international 2010;105(6):812-7.
2010: Giovanni Lughezzani; Claudio Jeldres; Hendrik Isbarn; Maxine Sun; Shahrokh F Shariat; Hugues Widmer; Philippe Arjane; Markus Graefen; Paul Perrotte; Francesco Montorsi; Pierre I Karakiewicz
Temporal stage and grade migration in surgically treated patients with upper tract urothelial carcinoma.
BJU international 2010;105(6):799-804.
2010: Naeem Bhojani; umberto capitanio; Nazareno Suardi; Claudio Jeldres; Hendrik Isbarn; Shahrokh F Shariat; Markus Graefen; Philippe Arjane; AJ Duclos; Jean-Baptiste Lattouf; Fred Saad; Luc Valiquette; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients.
International journal of radiation oncology, biology, physics 2010;76(2):342-8.
2010: Sara Baillargeon-Gagné; Claudio Jeldres; Giovanni Lughezzani; Maxine Sun; Hendrik Isbarn; umberto capitanio; Shahrokh F Shariat; Maxime Crépel; Ahmed Alasker; Hugues Widmer; Philippe Arjane; Jean-Jacques Patard; Paul Perrotte; Francesco Montorsi; Markus Graefen; Pierre I Karakiewicz
A comparative population-based analysis of the rate of partial vs radical nephrectomy for clinically localized renal cell carcinoma.
BJU international 2010;105(3):359-64.
2010: Giovanni Lughezzani; Maxine Sun; Claudio Jeldres; Ahmed Alasker; Lars Budäus; Shahrokh F Shariat; Mathieu Latour; Hugues Widmer; AJ Duclos; Martine Jolivet-Tremblay; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Adenocarcinoma versus urothelial carcinoma of the urinary bladder: comparison between pathologic stage at radical cystectomy and cancer-specific mortality.
Urology 2010;75(2):376-81.
2010: Maxime Crépel; Claudio Jeldres; Paul Perrotte; umberto capitanio; Hendrik Isbarn; Shahrokh F Shariat; Daniel Liberman; Maxine Sun; Giovanni Lughezzani; Philippe Arjane; Hugues Widmer; Markus Graefen; Francesco Montorsi; Jean-Jacques Patard; Pierre I Karakiewicz
Nephron-sparing surgery is equally effective to radical nephrectomy for T1BN0M0 renal cell carcinoma: a population-based assessment.
Urology 2010;75(2):271-5.
2010: Giovanni Lughezzani; Maxine Sun; Paul Perrotte; Shahrokh F Shariat; Claudio Jeldres; Lars Budäus; Mathieu Latour; Hugues Widmer; AJ Duclos; Francois Bénard; Michael McCormack; Francesco Montorsi; Pierre I Karakiewicz
Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database.
Urology 2010;75(2):321-7.
2010: Shahrokh F Shariat; John P Sfakianos; Michael J Droller; Pierre I Karakiewicz; Siegfried Meryn; Bernard H Bochner
The effect of age and gender on bladder cancer: a critical review of the literature.
BJU international 2010;105(3):300-8.
2010: Hans-Martin Fritsche; Maximilian Burger; Robert S Svatek; Claudio Jeldres; Pierre I Karakiewicz; Giacomo Novara; Eila Skinner; Stefan Denzinger; Yves Fradet; Hendrik Isbarn; Patrick J Bastian; Bjoern G Volkmer; Francesco Montorsi; Wassim Kassouf; Derya Tilki; Wolfgang Otto; Umberto Capitanio; Jonathan I Izawa; Vincenzo Ficarra; Seth Lerner; Arthur I Sagalowsky; Mark P Schoenberg; Ashish Kamat; Colin P Dinney; Yair Lotan; Shahrokh F Shariat
Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort.
European urology 2010;57(2):300-9.
2010: Shahrokh F Shariat; Christian Bolenz; Pierre I Karakiewicz; Yves Fradet; Raheela Ashfaq; Patrick J Bastian; Matthew Nielsen; Umberto Capitanio; Claudio Jeldres; Jérôme Rigaud; Stefan C Müller; Seth P Lerner; Francesco Montorsi; Arthur I Sagalowsky; Richard J Cote; Yair Lotan
p53 expression in patients with advanced urothelial cancer of the urinary bladder.
BJU international 2010;105(4):489-95.
2010: William T Lowrance; Tatum V Tarin; Shahrokh F Shariat
Evidence-based comparison of robotic and open radical prostatectomy.
TheScientificWorldJournal 2010;10():2228-37.
2010: Derya Tilki; Robert S Svatek; Pierre I Karakiewicz; Hendrik Isbarn; Oliver Reich; Wassim Kassouf; Yves Fradet; Giacomo Novara; Hans-Martin Fritsche; Patrick J Bastian; Jonathan I Izawa; Christian G Stief; Vincenzo Ficarra; Seth P Lerner; Mark P Schoenberg; Colin P Dinney; Eila Skinner; Yair Lotan; Arthur I Sagalowsky; Shahrokh F Shariat
Characteristics and outcomes of patients with pT4 urothelial carcinoma at radical cystectomy: a retrospective international study of 583 patients.
The Journal of urology 2010;183(1):87-93.
2010: Shahrokh F Shariat; Daher C Chade; Pierre I Karakiewicz; Raheela Ashfaq; Hendrik Isbarn; Yves Fradet; Patrick J Bastian; Matthew Nielsen; Umberto Capitanio; Claudio Jeldres; Francesco Montorsi; Seth P Lerner; Arthur I Sagalowsky; Richard J Cote; Yair Lotan
Combination of multiple molecular markers can improve prognostication in patients with locally advanced and lymph node positive bladder cancer.
The Journal of urology 2010;183(1):68-75.
2010: Giovanni Lughezzani; Claudio Jeldres; Hendrik Isbarn; Shahrokh F Shariat; Maxine Sun; Daniel Pharand; Hugues Widmer; Philippe Arjane; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma.
Urology 2010;75(1):118-24.
2009: Giovanni Lughezzani; umberto capitanio; Claudio Jeldres; Hendrik Isbarn; Shahrokh F Shariat; Philippe Arjane; Hugues Widmer; Paul Perrotte; Francesco Montorsi; Pierre I Karakiewicz
Prognostic significance of lymph node invasion in patients with metastatic renal cell carcinoma: a population-based perspective.
Cancer 2009;115(24):5680-7.
2009: Shahrokh F Shariat; Michael W Kattan; Andrew J Vickers; Pierre I Karakiewicz; Peter T Scardino
Critical review of prostate cancer predictive tools.
Future oncology (London, England) 2009;5(10):1555-84.
2009: Pierre I Karakiewicz; Nazareno Suardi; umberto capitanio; Hendrik Isbarn; Claudio Jeldres; Paul Perrotte; Maxine Sun; Vincenzo Ficarra; Richard Zigeuner; Jacques Tostain; Arnaud Mejean; Luca Cindolo; Allan J Pantuck; Arie S Belldegrun; Laurent Zini; Alexandre de la Taille; Denis Chautard; Jean-Luc Descotes; Shahrokh F Shariat; Antoine Valeri; Peter F A Mulders; Hervé Lang; Eric Lechevallier; Jean-Jacques Patard
Conditional survival predictions after nephrectomy for renal cell carcinoma.
The Journal of urology 2009;182(6):2607-12.
2009: Giovanni Lughezzani; Claudio Jeldres; Hendrik Isbarn; Maxine Sun; Shahrokh F Shariat; Ahmed Alasker; Daniel Pharand; Hugues Widmer; Philippe Arjane; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients.
European journal of cancer (Oxford, England : 1990) 2009;45(18):3291-7.
2009: Christian Bolenz; Yair Lotan; Raheela Ashfaq; Shahrokh F Shariat
Estrogen and progesterone hormonal receptor expression in urothelial carcinoma of the bladder.
European urology 2009;56(6):1093-5.
2009: Laurent Zini; umberto capitanio; Claudio Jeldres; Giovanni Lughezzani; Maxine Sun; Shahrokh F Shariat; Hendrik Isbarn; Philippe Arjane; Hugues Widmer; Paul Perrotte; Markus Graefen; Francesco Montorsi; Pierre I Karakiewicz
External validation of a nomogram predicting mortality in patients with adrenocortical carcinoma.
BJU international 2009;104(11):1661-7.
2009: Vincent Cloutier; umberto capitanio; Laurent Zini; Paul Perrotte; Claudio Jeldres; Shahrokh F Shariat; Philippe Arjane; Jean-Jacques Patard; Francesco Montorsi; Pierre I Karakiewicz
Thirty-day mortality after nephrectomy: clinical implications for informed consent.
European urology 2009;56(6):998-1003.
2009: Shahrokh F Shariat; Pierre I Karakiewicz; Guilherme Godoy; Jose A Karam; Raheela Ashfaq; Yves Fradet; Hendrik Isbarn; Francesco Montorsi; Claudio Jeldres; Patrick J Bastian; Matthew Nielsen; Stefan C Müller; Arthur I Sagalowsky; Yair Lotan
Survivin as a prognostic marker for urothelial carcinoma of the bladder: a multicenter external validation study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(22):7012-9.
2009: Daher C Chade; Shahrokh F Shariat; Guido Dalbagni
Intravesical therapy for urothelial carcinoma of the urinary bladder: a critical review.
International braz j urol : official journal of the Brazilian Society of Urology 2009;35(6):640-50; discussion 651.
2009: Marco Roscigno; Shahrokh F Shariat; Massimo Freschi; Vitaly Margulis; Pierre Karakiewizc; Nazareno Suardi; Mesut Remzi; Richard Zigeuner; Christian Bolenz; Eiji Kikuchi; Alon Z Weizer; Karim Bensalah; Arthur Sagalowsky; Theresa Koppie; Jay Raman; Mario Fernández; Philipp Ströbel; Wareef Kabbani; Cord Langner; Jeffery Wheat; Charles C Guo; Wassim Kassouf; Andrea Haitel; Christopher G Wood; Francesco Montorsi
Assessment of the minimum number of lymph nodes needed to detect lymph node invasion at radical nephroureterectomy in patients with upper tract urothelial cancer.
Urology 2009;74(5):1070-4.
2009: Shahrokh F Shariat; Matthew I Milowsky; Michael J Droller
Bladder cancer in the elderly.
Urologic oncology 2009;27(6):653-67.
2009: Hendrik Isbarn; Claudio Jeldres; Shahrokh F Shariat; Daniel Liberman; Maxine Sun; Giovanni Lughezzani; Hugues Widmer; Philippe Arjane; Daniel Pharand; Margit Fisch; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma.
The Journal of urology 2009;182(5):2177-81.
2009: Maxine Sun; Giovanni Lughezzani; Claudio Jeldres; Hendrik Isbarn; Shahrokh F Shariat; Philippe Arjane; Hugues Widmer; Daniel Pharand; Mathieu Latour; Paul Perrotte; Jean-Jacques Patard; Pierre I Karakiewicz
A proposal for reclassification of the Fuhrman grading system in patients with clear cell renal cell carcinoma.
European urology 2009;56(5):775-81.
2009: Claudio Jeldres; Héloise Cardinal; AJ Duclos; Shahrokh F Shariat; Nazareno Suardi; umberto capitanio; Marie-Josèe Hébert; Pierre I Karakiewicz
Prediction of delayed graft function after renal transplantation.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada 2009;3(5):377-82.
2009: Giovanni Lughezzani; Claudio Jeldres; Hendrik Isbarn; Paul Perrotte; Shahrokh F Shariat; Maxine Sun; Hugues Widmer; Philippe Arjane; Francois Peloquin; Daniel Pharand; Jean-Jacques Patard; Markus Graefen; Francesco Montorsi; Pierre I Karakiewicz
Tumor size is a determinant of the rate of stage T1 renal cell cancer synchronous metastasis.
The Journal of urology 2009;182(4):1287-93.
2009: Maxime Crépel; Hendrik Isbarn; umberto capitanio; Daniel Liberman; Claudio Jeldres; Maxine Sun; Shahrokh F Shariat; Hugues Widmer; Philippe Arjane; Markus Graefen; Francesco Montorsi; Jean-Jacques Patard; Paul Perrotte; Pierre I Karakiewicz
Does histologic subtype affect oncologic outcomes after nephron-sparing surgery?
Urology 2009;74(4):842-5.
2009: Umberto Capitanio; Hendrik Isbarn; Shahrokh F Shariat; Claudio Jeldres; Laurent Zini; Fred Saad; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Partial cystectomy does not undermine cancer control in appropriately selected patients with urothelial carcinoma of the bladder: a population-based matched analysist.
Urology 2009;74(4):858-64.
2009: Claudio Jeldres; Sara Baillargeon-Gagne; Daniel Liberman; Hendrik Isbarn; umberto capitanio; Shahrokh F Shariat; Maxine Sun; Giovanni Lughezzani; Paul Perrotte; Francesco Montorsi; Markus Graefen; Pierre I Karakiewicz
A population-based analysis of the rate of cytoreductive nephrectomy for metastatic renal cell carcinoma in the United States.
Urology 2009;74(4):837-41.
2009: Shahrokh F Shariat
Editorial comment on: Large-scale real-time reverse transcription-PCR approach of angiogenic pathways in human transitional cell carcinoma of the bladder: identification of VEGFA as a major independent prognostic marker.
European urology 2009;56(4):688-9.
2009: Guilherme Godoy; Daher C Chade; Shahrokh F Shariat
Words of wisdom. Re: Pathologic stage T2a and T2b prostate cancer in the recent prostate-specific antigen era: implications for unilateral ablative therapy. Polascik TJ, Mayes JM, Sun L, Madden JF, Moul JW, Mouraviev V.
European urology 2009;56(3):573-5.
2009: Geoffrey R Nuss; Allen F Morey; Adam C Jenkins; Jeffrey H Pruitt; Daniel D Dugi; Brian Morse; Shahrokh F Shariat
Radiographic predictors of need for angiographic embolization after traumatic renal injury.
The Journal of trauma 2009;67(3):578-82; discussion 582.
2009: Shahrokh F Shariat; Yair Lotan; Pierre I Karakiewicz; Raheela Ashfaq; Hendrik Isbarn; Yves Fradet; Patrick J Bastian; Matthew Nielsen; Umberto Capitanio; Claudio Jeldres; Francesco Montorsi; Stefan C Müller; Jose A Karam; Lukas Heukamp; GEORGES NETTO; Seth P Lerner; Arthur I Sagalowsky; Richard J Cote
p53 predictive value for pT1-2 N0 disease at radical cystectomy.
The Journal of urology 2009;182(3):907-13.
2009: Nicholas J Hellenthal; Shahrokh F Shariat; Vitaly Margulis; Pierre I Karakiewicz; Marco Roscigno; Christian Bolenz; Mesut Remzi; Alon Z Weizer; Richard Zigeuner; Karim Bensalah; Casey K Ng; Jay D Raman; Eiji Kikuchi; Francesco Montorsi; Mototsugu Oya; Christopher G Wood; Mario Fernandez; Christopher P Evans; Theresa Koppie
Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration.
The Journal of urology 2009;182(3):900-6.
2009: Marco Roscigno; Shahrokh F Shariat; Vitaly Margulis; Pierre Karakiewicz; Mesut Remzi; Eiji Kikuchi; Richard Zigeuner; Alon Z Weizer; Arthur Sagalowsky; Karim Bensalah; Jay D Raman; Christian Bolenz; Wassim Kassou; Theresa Koppie; Christopher G Wood; Jeffrey Wheat; Cord Langner; Casey K Ng; umberto capitanio; Roberto Bertini; Mario I Fernández; Shuji Mikami; Masaru Isida; Philipp Ströbel; Francesco Montorsi
The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed?
European urology 2009;56(3):512-8.
2009: umberto capitanio; Paul Perrotte; Laurent Zini; Claudio Jeldres; Shahrokh F Shariat; Hendrik Isbarn; Philippe Arjane; François Peloquin; Daniel Pharand; Francesco Montorsi; Pierre I Karakiewicz
Nephrectomy improves survival in patients with invasion of adjacent viscera and absence of nodal metastases (stage T4N0 renal cell carcinoma).
BJU international 2009;104(6):795-9.
2009: Hendrik Isbarn; Claudio Jeldres; umberto capitanio; Laurent Zini; Shahrokh F Shariat; Giovanni Lughezzani; Maxine Sun; Sascha A Ahyai; AJ Duclos; Martine Jolivet-Tremblay; Jean-Baptiste Lattouf; Luc Valiquette; Paul Perrotte; Francesco Montorsi; Markus Graefen; Pierre I Karakiewicz
Thirty-day mortality after transurethral resection of the prostate in patients treated with androgen deprivation therapy.
Journal of endourology / Endourological Society 2009;23(8):1347-52.
2009: Claudio Jeldres; Hendrik Isbarn; umberto capitanio; Laurent Zini; Naeem Bhojani; Shahrokh F Shariat; Vincent Cloutier; Jean-Baptiste Lattouf; AJ Duclos; Martine Jolivet-Tremblay; Luc Valiquette; Fred Saad; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Development and external validation of a highly accurate nomogram for the prediction of perioperative mortality after transurethral resection of the prostate for benign prostatic hyperplasia.
The Journal of urology 2009;182(2):626-32.
2009: Hendrik Isbarn; Pierre I Karakiewicz; Shahrokh F Shariat; umberto capitanio; Ganesh S Palapattu; Arthur I Sagalowsky; Yair Lotan; Mark P Schoenberg; Gilad E Amiel; Seth P Lerner; Guru Sonpavde
Residual pathological stage at radical cystectomy significantly impacts outcomes for initial T2N0 bladder cancer.
The Journal of urology 2009;182(2):459-65; discussion 465.
2009: umberto capitanio; Claudio Jeldres; Paul Perrotte; Hendrik Isbarn; Maxime Crépel; Vincent Cloutier; Sara Baillargeon-Gagne; Shahrokh F Shariat; AJ Duclos; Philippe Arjane; Hugues Widmer; Fred Saad; Francesco Montorsi; Pierre I Karakiewicz
Population-based study of perioperative mortality after retroperitoneal lymphadenectomy for nonseminomatous testicular germ cell tumors.
Urology 2009;74(2):373-7.
2009: Hendrik Isbarn; Claudio Jeldres; Laurent Zini; Paul Perrotte; Sara Baillargeon-Gagne; umberto capitanio; Shahrokh F Shariat; Phillipe Arjane; Fred Saad; Michael McCormack; Luc Valiquette; Francois Peloquin; AJ Duclos; Francesco Montorsi; Markus Graefen; Pierre I Karakiewicz
A population based assessment of perioperative mortality after cystectomy for bladder cancer.
The Journal of urology 2009;182(1):70-7.
2009: Shahrokh F Shariat; Christian Bolenz; Guilherme Godoy; Yves Fradet; Raheela Ashfaq; Pierre I Karakiewicz; Hendrik Isbarn; Claudio Jeldres; Jérôme Rigaud; Arthur I Sagalowsky; Yair Lotan
Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.
The Journal of urology 2009;182(1):78-84; discussion 84.
2009: umberto capitanio; Shahrokh F Shariat; Hendrik Isbarn; Alon Z Weizer; Mesut Remzi; Marco Roscigno; Eiji Kikuchi; Jay D Raman; Christian Bolenz; Karim Bensalah; Theresa Koppie; Wassim Kassouf; Mario I Fernández; Philipp Ströbel; Jeffrey Wheat; Richard Zigeuner; Cord Langner; Matthias Waldert; Mototsugu Oya; Charles C Guo; Casey Ng; Francesco Montorsi; Christopher G Wood; Vitaly Margulis; Pierre I Karakiewicz
Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases.
European urology 2009;56(1):1-9.
2009: umberto capitanio; Paul Perrotte; Laurent Zini; Nazareno Suardi; Elie Antebi; Vincent Cloutier; Claudio Jeldres; Shahrokh F Shariat; AJ Duclos; Philippe Arjane; Fred Saad; Francesco Montorsi; Pierre I Karakiewicz
Population-based analysis of normal Total PSA and percentage of free/Total PSA values: results from screening cohort.
Urology 2009;73(6):1323-7.
2009: Marco Roscigno; Shahrokh F Shariat; Vitaly Margulis; Pierre Karakiewicz; Mesut Remzi; Eiji Kikuchi; Cord Langner; Yair Lotan; Alon Z Weizer; Karim Bensalah; Jay D Raman; Christian Bolenz; Charles C Guo; Christopher G Wood; Richard Zigeuner; Jeffrey Wheat; Wareef Kabbani; Theresa Koppie; Casey Ng; Nazareno Suardi; Roberto Bertini; Mario I Fernández; Shuji Mikami; Masaru Isida; Maurice Stephan Michel; Francesco Montorsi
Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.
The Journal of urology 2009;181(6):2482-9.
2009: Robert S Svatek; Claudio Jeldres; Pierre I Karakiewicz; Nazareno Suardi; Jochen Walz; Claus G Roehrborn; Francesco Montorsi; Kevin Slawin; Shahrokh F Shariat
Pre-treatment biomarker levels improve the accuracy of post-prostatectomy nomogram for prediction of biochemical recurrence.
The Prostate 2009;69(8):886-94.
2009: umberto capitanio; Vincent Cloutier; Laurent Zini; Hendrik Isbarn; Claudio Jeldres; Shahrokh F Shariat; Paul Perrotte; Elie Antebi; Jean-Jacques Patard; Francesco Montorsi; Pierre I Karakiewicz
A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population-based study.
BJU international 2009;103(11):1496-500.
2009: Yair Lotan; umberto capitanio; Shahrokh F Shariat; Georg C Hutterer; Pierre I Karakiewicz
Impact of clinical factors, including a point-of-care nuclear matrix protein-22 assay and cytology, on bladder cancer detection.
BJU international 2009;103(10):1368-74.
2009: umberto capitanio; Nazareno Suardi; Shahrokh F Shariat; Yair Lotan; Ganesh S Palapattu; Patrick J Bastian; Amit Gupta; Amnon Vazina; Mark P Schoenberg; Seth P Lerner; Arthur I Sagalowsky; Pierre I Karakiewicz
Assessing the minimum number of lymph nodes needed at radical cystectomy in patients with bladder cancer.
BJU international 2009;103(10):1359-62.
2009: Amit Gupta; Yair Lotan; Raheela Ashfaq; Claus G Roehrborn; Ganesh V Raj; Corinne C Aragaki; Francesco Montorsi; Shahrokh F Shariat
Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patients.
European urology 2009;55(5):1124-33.
2009: Shahrokh F Shariat; Guilherme Godoy; Pierre I Karakiewicz; Seth P Lerner
Use of nomograms for predictions of outcome in patients with advanced bladder cancer.
Therapeutic advances in urology 2009;1(1):13-26.
2009: Laurent Zini; Paul Perrotte; umberto capitanio; Claudio Jeldres; Shahrokh F Shariat; Elie Antebi; Fred Saad; Jean-Jacques Patard; Francesco Montorsi; Pierre I Karakiewicz
Radical versus partial nephrectomy: effect on overall and noncancer mortality.
Cancer 2009;115(7):1465-71.
2009: Kevin C Zorn; Umberto Capitanio; Claudio Jeldres; Philippe Arjane; Paul Perrotte; Shahrokh F Shariat; David I Lee; Arieh L Shalhav; Gregory P Zagaja; Sergey A Shikanov; Ofer N Gofrit; Alan E Thong; David M Albala; Leon Sun; Pierre I Karakiewicz
Multi-institutional external validation of seminal vesicle invasion nomograms: head-to-head comparison of Gallina nomogram versus 2007 Partin tables.
International journal of radiation oncology, biology, physics 2009;73(5):1461-7.
2009: Vitaly Margulis; Shahrokh F Shariat; Surena F Matin; Ashish M Kamat; Richard Zigeuner; Eiji Kikuchi; Yair Lotan; Alon Z Weizer; Jay D Raman; Christopher G Wood
Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration.
Cancer 2009;115(6):1224-33.
2009: Shahrokh F Shariat; Robert S Svatek
Editorial comment on: Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy.
European urology 2009;55(3):626-8.
2009: Laurent Zini; Vincent Cloutier; Hendrik Isbarn; Paul Perrotte; umberto capitanio; Claudio Jeldres; Shahrokh F Shariat; Fred Saad; Philippe Arjane; AJ Duclos; Jean-Baptiste Lattouf; Francesco Montorsi; Pierre I Karakiewicz
A simple and accurate model for prediction of cancer-specific mortality in patients treated with surgery for primary penile squamous cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(3):1013-8.
2009: Eiji Kikuchi; Vitaly Margulis; Pierre I Karakiewicz; Marco Roscigno; Shuji Mikami; Yair Lotan; Mesut Remzi; Christian Bolenz; Cord Langner; Alon Z Weizer; Francesco Montorsi; Karim Bensalah; Theresa Koppie; Mario I Fernández; Jay D Raman; Wassim Kassouf; Christopher G Wood; Nazareno Suardi; Mototsugu Oya; Shahrokh F Shariat
Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(4):612-8.
2009: Laurent Zini; umberto capitanio; Paul Perrotte; Claudio Jeldres; Shahrokh F Shariat; Philippe Arjane; Hugues Widmer; Francesco Montorsi; Jean-Jacques Patard; Pierre I Karakiewicz
Population-based assessment of survival after cytoreductive nephrectomy versus no surgery in patients with metastatic renal cell carcinoma.
Urology 2009;73(2):342-6.
2009: Naeem Bhojani; Laurent Salomon; umberto capitanio; Nazareno Suardi; Shahrokh F Shariat; Claudio Jeldres; Laurent Zini; Daniel Pharand; François Péloquin; Philippe Arjane; Claude C Abbou; Alexandre de la Taille; Francesco Montorsi; Pierre I Karakiewicz
External validation of the updated partin tables in a cohort of French and Italian men.
International journal of radiation oncology, biology, physics 2009;73(2):347-52.
2009: Christian Bolenz; Shahrokh F Shariat; Mario I Fernández; Vitaly Margulis; Yair Lotan; Pierre Karakiewicz; Mesut Remzi; Eiji Kikuchi; Richard Zigeuner; Alon Z Weizer; Francesco Montorsi; Karim Bensalah; Christopher G Wood; Marco Roscigno; Cord Langner; Theresa Koppie; Jay D Raman; Shuji Mikami; Maurice Stephan Michel; Philipp Ströbel
Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph-node density.
BJU international 2009;103(3):302-6.
2009: Mesut Remzi; Andrea Haitel; Vitaly Margulis; Pierre Karakiewicz; Pierre Karakiewizc; Francesco Montorsi; Eiji Kikuchi; Richard Zigeuner; Alon Z Weizer; Christian Bolenz; Karim Bensalah; Nazareno Suardi; Jay D Raman; Yair Lotan; Matthias Waldert; Casey Ng; Mario Fernández; Theresa Koppie; Philipp Ströbel; Wareef Kabbani; Masaru Murai; Cord Langner; Marco Roscigno; Jeffrey Wheat; Charles C Guo; Christopher G Wood; Shahrokh F Shariat
Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients.
BJU international 2009;103(3):307-11.
2009: Shahrokh F Shariat; Umberto Capitanio; Claudio Jeldres; Pierre I Karakiewicz
Can nomograms be superior to other prediction tools?
BJU international 2009;103(4):492-5; discussion 495-7.
2009: N Bhojani; Sascha A Ahyai; Markus Graefen; umberto capitanio; Nazareno Suardi; Shahrokh F Shariat; Claudio Jeldres; Andreas Erbersdobler; Thorsten Schlomm; Alexander Haese; Thomas Steuber; Hans Heinzer; Francesco Montorsi; Hartwig Huland; Pierre I Karakiewicz
Partin Tables cannot accurately predict the pathological stage at radical prostatectomy.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2009;35(2):123-8.
2009: Vitaly Margulis; Yair Lotan; Pierre I Karakiewicz; Yves Fradet; Raheela Ashfaq; Umberto Capitanio; Francesco Montorsi; Patrick J Bastian; Matthew Nielsen; Stefan C Müller; Jérôme Rigaud; Lukas Heukamp; GEORGES NETTO; Seth P Lerner; Arthur I Sagalowsky; Shahrokh F Shariat
Multi-institutional validation of the predictive value of Ki-67 labeling index in patients with urinary bladder cancer.
Journal of the National Cancer Institute 2009;101(2):114-9.
2009: Shahrokh F Shariat; Jose A Karam; Pierre I Karakiewicz
Words of wisdom. Re: Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. Hudes G, Carducci M, Tomczak P, Dutcher J, Figlin R, Kapoor A, Staroslawska E, Sosman J, McDermott D, Bodrogi I, Kovacevic Z, Lesovoy V, Schmidt-Wolf IG, Barbarash O, Gokmen E, O'Toole T, Lustgarten S, Moore L, Motzer RJ; Global ARCC Trial. N Engl J Med 2007;356:2271-81.
European urology 2009;55(1):250-2.
2009: Shahrokh F Shariat; Kai Hans Hammerich
Words of wisdom. Re: Timing of androgen deprivation therapy and its impact on survival after radical prostatectomy: a matched cohort study. Siddiqui SA, Boorjian SA, Inman B, Bagniewski S, Bergstralh EJ, Blute ML. J Urol 2008;179:1830-7; discussion 1837.
European urology 2009;55(1):245-6.
2009: Shahrokh F Shariat; Philippe E Zimmern; Kathleen Hilton; Rebecca S Gruchalla
Prospective questionnaire-based evaluation of the prevalence of urinary incontinence in women with chronic cough.
Urologia internationalis 2009;83(2):181-6.
2009: umberto capitanio; Paul Perrotte; Georg C Hutterer; Nazareno Suardi; Claudio Jeldres; Shahrokh F Shariat; Alain Duclos; Philippe Arjane; Francesco Montorsi; Pierre I Karakiewicz
Effect of body mass index on prostate-specific antigen and percentage free prostate-specific antigen: results from a prostate cancer screening cohort of 1490 men.
International journal of urology : official journal of the Japanese Urological Association 2009;16(1):91-5.
2009: Mario I Fernández; Shahrokh F Shariat; Vitaly Margulis; Christian Bolenz; Francesco Montorsi; Nazareno Suardi; Mesut Remzi; Christopher G Wood; Marco Roscigno; Eiji Kikuchi; Mototsugu Oya; Richard Zigeuner; Cord Langner; Alon Z Weizer; Yair Lotan; Theresa Koppie; Jay D Raman; Pierre Karakiewicz; Pierre Karakiewizc; Karim Bensalah; Marcela Schultz; Pablo Bernier
Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter study.
Urology 2009;73(1):142-6.
2009: Robert S Svatek; Shahrokh F Shariat
Editorial comment on: Potential impact of postoperative early complications on the timing of adjuvant chemotherapy in patients undergoing radical cystectomy: a high-volume tertiary cancer center experience.
European urology 2009;55(1):185-6.
2008: Shahrokh F Shariat; Peter T Scardino; Hans Lilja
Screening for prostate cancer: an update.
The Canadian journal of urology 2008;15(6):4363-74.
2008: Shahrokh F Shariat; Pierre I Karakiewicz; Claus G Roehrborn; Michael W Kattan
An updated catalog of prostate cancer predictive tools.
Cancer 2008;113(11):3075-99.
2008: umberto capitanio; Sascha A Ahyai; Markus Graefen; Claudio Jeldres; Shahrokh F Shariat; Andreas Erbersdobler; Thorsten Schlomm; Alexander Haese; Thomas Steuber; Hans Heinzer; Paul Perrotte; François Péloquin; Daniel Pharand; Philippe Arjane; Hartwig Huland; Pierre I Karakiewicz
Assessment of biochemical recurrence rate in patients with pathologically confirmed insignificant prostate cancer.
Urology 2008;72(6):1208-11; discussion 1212-3.
2008: Amit Gupta; Pierre I Karakiewicz; Claus G Roehrborn; Yair Lotan; Alexandre R Zlotta; Shahrokh F Shariat
Predictive value of plasma hepatocyte growth factor/scatter factor levels in patients with clinically localized prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(22):7385-90.
2008: Jose A Karam; Shahrokh F Shariat; Jer-Tsong Hsieh; Margaret A Knowles
Genomics: a preview of genomic medicine.
BJU international 2008;102(9 Pt B):1221-7.
2008: umberto capitanio; Laurent Zini; Paul Perrotte; Shahrokh F Shariat; Claudio Jeldres; Philippe Arjane; Daniel Pharand; Hugues Widmer; François Péloquin; Francesco Montorsi; Jean-Jacques Patard; Pierre I Karakiewicz
Cytoreductive partial nephrectomy does not undermine cancer control in metastatic renal cell carcinoma: a population-based study.
Urology 2008;72(5):1090-5.
2008: Shahrokh F Shariat; Claus G Roehrborn; Dolores J Lamb; Kevin Slawin
Notice of duplicate publication: "Potentially harmful effect of a testosterone dietary supplement on prostate cancer growth and metastasis" (arch intern med. 2008;168[2]:235-236).
Archives of internal medicine 2008;168(18):2046-7.
2008: Shahrokh F Shariat; Christian Bolenz; Pierre I Karakiewicz
Words of wisdom. Re: Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial. Escudier B, Pluzanska A, Koralewski P, et al., for the AVOREN Trial investigators.
European urology 2008;54(4):948-9.
2008: umberto capitanio; Alberto Briganti; Shahrokh F Shariat; Pierre I Karakiewicz
The importance of the quantification of the extent of cancer in prostatic biopsies in prediction of biochemical recurrence: a global perspective.
European urology 2008;54(4):717-9.
2008: Shahrokh F Shariat
Editorial comment on: Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer.
European urology 2008;54(4):803-4.
2008: umberto capitanio; Claudio Jeldres; Shahrokh F Shariat; Pierre I Karakiewicz
Clinicians are most familiar with nomograms and rate their clinical usefulness highest, look-up tables are second best.
European urology 2008;54(4):958-9.
2008: Jose A Karam; Vitaly Margulis; Francesco Montorsi; Pierre I Karakiewicz; Yair Lotan; Eiji Kikuchi; Alon Z Weizer; Richard Zigeuner; Christian Bolenz; Shahrokh F Shariat
Carcinoma in situ of the upper urinary tract treated with radical nephroureterectomy--results from a multicenter study.
European urology 2008;54(4):961-3.
2008: Robert S Svatek; Shahrokh F Shariat
Re: lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC.
European urology 2008;54(3):690-1.
2008: Pierre I Karakiewicz; Naeem Bhojani; umberto capitanio; Alwyn M Reuther; Nazareno Suardi; Claudio Jeldres; Daniel Pharand; François Péloquin; Paul Perrotte; Shahrokh F Shariat; Eric A Klein
External validation of the updated Partin tables in a cohort of North American men.
The Journal of urology 2008;180(3):898-902; discussion 902-3.
2008: Shahrokh F Shariat; Adam Jenkins; Claus G Roehrborn; Jose A Karam; Key H Stage; Pierre I Karakiewicz
Features and outcomes of patients with grade IV renal injury.
BJU international 2008;102(6):728-33; discussion 733.
2008: Naeem Bhojani; Paul Perrotte; Georg C Hutterer; Nazareno Suardi; Claudio Jeldres; Shahrokh F Shariat; umberto capitanio; Philippe Arjane; Hugues Widmer; Francois Benard; Francois Peloquin; Francesco Montorsi; Pierre I Karakiewicz
Body mass index and its association with genitourinary disorders in men undergoing prostate cancer screening.
The journal of sexual medicine 2008;5(9):2141-51.
2008: Claudio Jeldres; Nazareno Suardi; umberto capitanio; Francesco Montorsi; Shahrokh F Shariat; Paul Perrotte; Francois Peloquin; Daniel Pharand; Markus Graefen; Pierre I Karakiewicz
High surgical volume is associated with a lower rate of secondary therapy after radical prostatectomy for localized prostate cancer.
BJU international 2008;102(4):463-7.
2008: Andrea Gallina; Nazareno Suardi; Francesco Montorsi; umberto capitanio; Claudio Jeldres; Fred Saad; Markus Graefen; Shahrokh F Shariat; Hugues Widmer; Philippe Arjane; François Péloquin; Paul Perrotte; Pierre I Karakiewicz
Mortality at 120 days after prostatic biopsy: a population-based study of 22,175 men.
International journal of cancer. Journal international du cancer 2008;123(3):647-52.
2008: Shahrokh F Shariat; Pierre I Karakiewicz; Nazareno Suardi; Michael W Kattan
Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(14):4400-7.
2008: Jochen Walz; Nazareno Suardi; Shahrokh F Shariat; Claudio Jeldres; Paul Perrotte; Markus Graefen; Hughes Widmer; Philippe Arjane; Luc Valiquette; Georg C Hutterer; Fred Saad; Pierre I Karakiewicz
Accuracy of life tables in predicting overall survival in patients after radical prostatectomy.
BJU international 2008;102(1):33-8.
2008: Shahrokh F Shariat; Vitaly Margulis; Pierre I Karakiewicz
Rebuttal from authors re: James W.F. Catto. More nomograms or better evidence of efficacy: what do we need in urologic oncology? Eur Urol 2008;54:11-12.
European urology 2008;54(1):13-5.
2008: Vitaly Margulis; Yair Lotan; Francesco Montorsi; Shahrokh F Shariat
Predicting survival after radical cystectomy for bladder cancer.
BJU international 2008;102(1):15-22.
2008: Shahrokh F Shariat; Pierre I Karakiewicz
Perspectives on prostate cancer biomarkers.
European urology 2008;54(1):8-10.
2008: Shahrokh F Shariat; Vitaly Margulis; Yair Lotan; Francesco Montorsi; Pierre I Karakiewicz
Nomograms for bladder cancer.
European urology 2008;54(1):41-53.
2008: Claudio Jeldres; Nazareno Suardi; Fred Saad; Francesco Montorsi; Shahrokh F Shariat; Paul Perrotte; Naeem Bhojani; Jochen Walz; Georg C Hutterer; Markus Graefen; Luc Valiquette; Pierre I Karakiewicz
High provider volume is associated with lower rate of secondary therapies after definitive radiotherapy for localized prostate cancer.
European urology 2008;54(1):97-105.
2008: Claudio Jeldres; Nazareno Suardi; Jochen Walz; Fred Saad; Georg C Hutterer; Naeem Bhojani; Shahrokh F Shariat; Paul Perrotte; Markus Graefen; Francesco Montorsi; Pierre I Karakiewicz
Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: a population-based study of 6183 men.
European urology 2008;54(1):107-16.
2008: Shahrokh F Shariat; Jose A Karam; Jochen Walz; Claus G Roehrborn; Francesco Montorsi; Vitaly Margulis; Fred Saad; Kevin Slawin; Pierre I Karakiewicz
Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(12):3785-91.
2008: Shahrokh F Shariat; Quoc-Dien Trinh; Allen F Morey; Key H Stage; Claus G Roehrborn; Luc Valiquette; Pierre I Karakiewicz
Development of a highly accurate nomogram for prediction of the need for exploration in patients with renal trauma.
The Journal of trauma 2008;64(6):1451-8.
2008: Robert S Svatek; Jose A Karam; Claus G Roehrborn; Pierre I Karakiewicz; Kevin Slawin; Shahrokh F Shariat
Preoperative plasma endoglin levels predict biochemical progression after radical prostatectomy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(11):3362-6.
2008: Jochen Walz; Shahrokh F Shariat; Nazareno Suardi; Paul Perrotte; Yair Lotan; Ganesh S Palapattu; Amit Gupta; Patrick J Bastian; Craig G Rogers; Amnon Vazina; Gilad E Amiel; Arthur I Sagalowsky; Mark P Schoenberg; Seth P Lerner; Pierre I Karakiewicz
Adjuvant chemotherapy for bladder cancer does not alter cancer-specific survival after cystectomy in a matched case-control study.
BJU international 2008;101(11):1356-61.
2008: Yair Lotan; Karim Bensalah; Timothy Ruddell; Shahrokh F Shariat; Arthur I Sagalowsky; Raheela Ashfaq
Prospective evaluation of the clinical usefulness of reflex fluorescence in situ hybridization assay in patients with atypical cytology for the detection of urothelial carcinoma of the bladder.
The Journal of urology 2008;179(6):2164-9.
2008: Andrea Gallina; Felix K-H Chun; Nazareno Suardi; James A Eastham; Paul Perrotte; Markus Graefen; Georg C Hutterer; Hartwig Huland; Eric A Klein; Alwyn M Reuther; Francesco Montorsi; Alberto Briganti; Shahrokh F Shariat; Claus G Roehrborn; Alexandre de la Taille; Laurent Salomon; Pierre I Karakiewicz
Comparison of stage migration patterns between Europe and the USA: an analysis of 11 350 men treated with radical prostatectomy for prostate cancer.
BJU international 2008;101(12):1513-8.
2008: Yair Lotan; Shahrokh F Shariat
Impact of risk factors on the performance of the nuclear matrix protein 22 point-of-care test for bladder cancer detection.
BJU international 2008;101(11):1362-7.
2008: Shahrokh F Shariat; Pierre I Karakiewicz; Vitaly Margulis; Michael W Kattan
Inventory of prostate cancer predictive tools.
Current opinion in urology 2008;18(3):279-96.
2008: Shahrokh F Shariat; Jose A Karam; Jay D Raman
Urine cytology and urine-based markers for bladder urothelial carcinoma detection and monitoring: developments and future prospects.
Biomarkers in medicine 2008;2(2):165-80.
2008: Pierre I Karakiewicz; Naeem Bhojani; Alfred I Neugut; Shahrokh F Shariat; Claudio Jeldres; Markus Graefen; Paul Perrotte; Francois Peloquin; Michael W Kattan
The effect of comorbidity and socioeconomic status on sexual and urinary function and on general health-related quality of life in men treated with radical prostatectomy for localized prostate cancer.
The journal of sexual medicine 2008;5(4):919-27.
2008: Jochen Walz; Francesco Montorsi; Claudio Jeldres; Nazareno Suardi; Shahrokh F Shariat; Paul Perrotte; Philippe Arjane; Markus Graefen; Daniel Pharand; Pierre I Karakiewicz
The effect of surgical volume, age and comorbidities on 30-day mortality after radical prostatectomy: a population-based analysis of 9208 consecutive cases.
BJU international 2008;101(7):826-32.
2008: Shahrokh F Shariat; Jochen Walz; Claus G Roehrborn; Francesco Montorsi; Claudio Jeldres; Fred Saad; Pierre I Karakiewicz
Early postoperative plasma transforming growth factor-beta1 is a strong predictor of biochemical progression after radical prostatectomy.
The Journal of urology 2008;179(4):1593-7.
2008: Pierre I Karakiewicz; Nazareno Suardi; Shahrokh F Shariat
The search for better prognostic factors for men treated for localized prostate cancer continues.
European urology 2008;53(4):689-90.
2008: Shahrokh F Shariat; Jochen Walz; Claus G Roehrborn; Alexandre R Zlotta; Paul Perrotte; Nazareno Suardi; Fred Saad; Pierre I Karakiewicz
External validation of a biomarker-based preoperative nomogram predicts biochemical recurrence after radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(9):1526-31.
2008: Jose A Karam; Robert S Svatek; Pierre I Karakiewicz; Andrea Gallina; Claus G Roehrborn; Kevin Slawin; Shahrokh F Shariat
Use of preoperative plasma endoglin for prediction of lymph node metastasis in patients with clinically localized prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(5):1418-22.
2008: Georg C Hutterer; Pierre I Karakiewicz; Craig D Zippe; Gerson Lüdecke; Hans Boman; Marta Sanchez-Carbayo; Roberto Casella; Christine Mian; Martin G Friedrich; Sanaa Eissa; Hideyuki Akaza; Vincenzo Serretta; Hans Hedelin; Raina Rupesh; Naoto Miyanaga; Arthur I Sagalowsky; Paul Perrotte; Yair Lotan; Michael J Marberger; Shahrokh F Shariat
Urinary cytology and nuclear matrix protein 22 in the detection of bladder cancer recurrence other than transitional cell carcinoma.
BJU international 2008;101(5):561-5.
2008: Naeem Bhojani; Paul Perrotte; Claudio Jeldres; Nazareno Suardi; Georg C Hutterer; Shahrokh F Shariat; Pierre I Karakiewicz
The effect of comorbidities and socioeconomic status on sexual and urinary function in men undergoing prostate cancer screening.
The journal of sexual medicine 2008;5(3):668-76.
2008: Shahrokh F Shariat; Pierre I Karakiewicz
Screening for prostate cancer in 2007: the PSA era and its challenges are not over.
European urology 2008;53(3):457-60.
2008: Shahrokh F Shariat; Jose A Karam; Vitaly Margulis; Pierre I Karakiewicz
New blood-based biomarkers for the diagnosis, staging and prognosis of prostate cancer.
BJU international 2008;101(6):675-83.
2008: Robert S Svatek; Jose A Karam; Pierre I Karakiewicz; Andrea Gallina; Roberto Casella; Claus G Roehrborn; Shahrokh F Shariat
Role of urinary cathepsin B and L in the detection of bladder urothelial cell carcinoma.
The Journal of urology 2008;179(2):478-84; discussion 484.
2008: Vitaly Margulis; Yair Lotan; Shahrokh F Shariat
Survivin: a promising biomarker for detection and prognosis of bladder cancer.
World journal of urology 2008;26(1):59-65.
2008: Patrick J Bastian; Georg C Hutterer; Shahrokh F Shariat; Craig G Rogers; Ganesh S Palapattu; Yair Lotan; Amnon Vazina; Gilad E Amiel; Amit Gupta; Arthur I Sagalowsky; Seth P Lerner; Mark P Schoenberg; Pierre I Karakiewicz
Macroscopic, but not microscopic, perivesical fat invasion at radical cystectomy is an adverse predictor of recurrence and survival.
BJU international 2008;101(4):450-4.
2008: Shahrokh F Shariat; Dolores J Lamb; Claus G Roehrborn; Kevin Slawin
Potentially harmful effect of a testosterone dietary supplement on prostate cancer growth and metastasis.
Archives of internal medicine 2008;168(2):235-6.
2008: Shahrokh F Shariat; Dolores J Lamb; Radha G Iyengar; Claus G Roehrborn; Kevin Slawin
Herbal/hormonal dietary supplement possibly associated with prostate cancer progression.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(2):607-11.
2008: Shahrokh F Shariat; Pierre I Karakiewicz; Raheela Ashfaq; Seth P Lerner; Ganesh S Palapattu; Richard J Cote; Arthur I Sagalowsky; Yair Lotan
Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy.
Cancer 2008;112(2):315-25.
2008: Shahrokh F Shariat; Claus G Roehrborn
Using biopsy to detect prostate cancer.
Reviews in urology 2008;10(4):262-80.
2008: Shahrokh F Shariat; Jose A Karam; Yair Lotan; Pierre I Karakiewizc
Critical evaluation of urinary markers for bladder cancer detection and monitoring.
Reviews in urology 2008;10(2):120-35.
2008: Shahrokh F Shariat; Jose A Karam; Seth P Lerner
Molecular markers in bladder cancer.
Current opinion in urology 2008;18(1):1-8.
2008: Karim Bensalah; Yair Lotan; Jose A Karam; Shahrokh F Shariat
New circulating biomarkers for prostate cancer.
Prostate cancer and prostatic diseases 2008;11(2):112-20.
2008: Shahrokh F Shariat; Robert S Svatek; Wareef Kabbani; Jochen Walz; Yair Lotan; Pierre I Karakiewicz; Claus G Roehrborn
Prognostic value of syndecan-1 expression in patients treated with radical prostatectomy.
BJU international 2008;101(2):232-7.
2007: Alberto Briganti; Felix K-H Chun; Nazareno Suardi; Andrea Gallina; Jochen Walz; Markus Graefen; Shahrokh F Shariat; Andreas Ebersdobler; Patrizio Rigatti; Paul Perrotte; Fred Saad; Francesco Montorsi; Hartwig Huland; Pierre I Karakiewicz
Prostate volume and adverse prostate cancer features: fact not artifact.
European journal of cancer (Oxford, England : 1990) 2007;43(18):2669-77.
2007: Jochen Walz; Andrea Gallina; Paul Perrotte; Claudio Jeldres; Quoc-Dien Trinh; Georg C Hutterer; Miriam Traumann; Alvaro Ramirez; Shahrokh F Shariat; Michael McCormack; Jean-Paul Perreault; François Bénard; Luc Valiquette; Fred Saad; Pierre I Karakiewicz
Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer.
BJU international 2007;100(6):1254-8.
2007: Karim Bensalah; Francesco Montorsi; Shahrokh F Shariat
Challenges of cancer biomarker profiling.
European urology 2007;52(6):1601-9.
2007: Karim Bensalah; Olivier Traxer; Shahrokh F Shariat; Philippe E Zimmern
[What are the differences between American and French urologists?].
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie 2007;17(7):1367-71.
2007: Shahrokh F Shariat; Raheela Ashfaq; Arthur I Sagalowsky; Yair Lotan
Association of cyclin D1 and E1 expression with disease progression and biomarkers in patients with nonmuscle-invasive urothelial cell carcinoma of the bladder.
Urologic oncology 2007;25(6):468-75.
2007: Matthew Nielsen; Ganesh S Palapattu; Pierre I Karakiewicz; Yair Lotan; Patrick J Bastian; Seth P Lerner; Arthur I Sagalowsky; Mark P Schoenberg; Shahrokh F Shariat
A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome.
BJU international 2007;100(5):1015-20.
2007: Hong-Ying Huang; Shahrokh F Shariat; Tung-Tien Sun; Herbert Lepor; Ellen Shapiro; Jer-Tsong Hsieh; Raheela Ashfaq; Yair Lotan; Xue-Ru Wu
Persistent uroplakin expression in advanced urothelial carcinomas: implications in urothelial tumor progression and clinical outcome.
Human pathology 2007;38(11):1703-13.
2007: Andrea Gallina; Claudio Jeldres; Felix K-H Chun; Shahrokh F Shariat; Alberto Briganti; Jochen Walz; Claus G Roehrborn; Fred Saad; Hartwig Huland; Markus Graefen; Francesco Montorsi; Pierre I Karakiewicz
Prediction of pathological stage is inaccurate in men with PSA values above 20 ng/mL.
European urology 2007;52(5):1374-80.
2007: Shahrokh F Shariat; Sangtae Park; Quoc-Dien Trinh; Claus G Roehrborn; Kevin Slawin; Pierre I Karakiewicz
Plasminogen activation inhibitor-1 improves the predictive accuracy of prostate cancer nomograms.
The Journal of urology 2007;178(4 Pt 1):1229-36; discussion 1236-7.
2007: Felix K-H Chun; Alberto Briganti; Andrea Gallina; Georg C Hutterer; Shahrokh F Shariat; Elie Antebie; Jochen Walz; Claus G Roehrborn; Andrea Salonia; Patrizio Rigatti; Fred Saad; Hartwig Huland; Francesco Montorsi; Markus Graefen; Pierre I Karakiewicz
Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium.
European urology 2007;52(4):1067-74.
2007: Shahrokh F Shariat; Karim Bensalah; Jose A Karam; Claus G Roehrborn; Andrea Gallina; Yair Lotan; Kevin Slawin; Pierre I Karakiewicz
Preoperative plasma HER2 and epidermal growth factor receptor for staging and prognostication in patients with clinically localized prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(18 Pt 1):5377-84.
2007: Jose A Karam; Yair Lotan; Raheela Ashfaq; Arthur I Sagalowsky; Shahrokh F Shariat
Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
Urology 2007;70(3):482-6.
2007: Alberto Briganti; Shahrokh F Shariat; Felix K-H Chun; Georg C Hutterer; Claus G Roehrborn; Andrea Gallina; Patrizio Rigatti; Luc Valiquette; Francesco Montorsi; Pierre I Karakiewicz
Differences in the rate of lymph node invasion in men with clinically localized prostate cancer might be related to the continent of origin.
BJU international 2007;100(3):528-32.
2007: Jochen Walz; Andrea Gallina; Georg C Hutterer; Paul Perrotte; Shahrokh F Shariat; Markus Graefen; Michael McCormack; François Bénard; Luc Valiquette; Fred Saad; Pierre I Karakiewicz
Accuracy of life tables in predicting overall survival in candidates for radiotherapy for prostate cancer.
International journal of radiation oncology, biology, physics 2007;69(1):88-94.
2007: Alberto Briganti; Felix K-H Chun; Georg C Hutterer; Andrea Gallina; Shahrokh F Shariat; Andrea Salonia; Vincenzo Scattoni; Luc Valiquette; Francesco Montorsi; Patrizio Rigatti; Markus Graefen; Hartwig Huland; Pierre I Karakiewicz
Systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy.
European urology 2007;52(3):733-43.
2007: Jochen Walz; Andrea Gallina; Fred Saad; Francesco Montorsi; Paul Perrotte; Shahrokh F Shariat; Claudio Jeldres; Markus Graefen; François Bénard; Michael McCormack; Luc Valiquette; Pierre I Karakiewicz
A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(24):3576-81.
2007: Andrea Gallina; Pierre I Karakiewicz; Georg C Hutterer; Felix K-H Chun; Alberto Briganti; Jochen Walz; Elie Antebi; Shahrokh F Shariat; Nazareno Suardi; Markus Graefen; Andreas Erbersdobler; Andrea Salonia; Patrizio Rigatti; Hartwig Huland; Francesco Montorsi
Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men.
International journal of cancer. Journal international du cancer 2007;121(4):791-5.
2007: Jose A Karam; Shahrokh F Shariat; Hong-Ying Huang; Rey-Chen Pong; Raheela Ashfaq; Ellen Shapiro; Yair Lotan; Arthur I Sagalowsky; Xue-Ru Wu; Jer-Tsong Hsieh
Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(15 Pt 1):4400-6.
2007: Shahrokh F Shariat; Jose A Karam; Claus G Roehrborn
Blood biomarkers for prostate cancer detection and prognosis.
Future oncology (London, England) 2007;3(4):449-61.
2007: Bahaa S Malaeb; Hani H Rashid; Yair Lotan; Seyyed M Khoddami; Shahrokh F Shariat; Arthur I Sagalowsky; John D McConnell; Claus G Roehrborn; Kenneth S Koeneman
Prostate cancer disease-free survival after radical retropubic prostatectomy in patients older than 70 years compared to younger cohorts.
Urologic oncology 2007;25(4):291-7.
2007: Andrea Gallina; Felix K-H Chun; Alberto Briganti; Shahrokh F Shariat; Francesco Montorsi; Andrea Salonia; Andreas Erbersdobler; Patrizio Rigatti; Luc Valiquette; Hartwig Huland; Markus Graefen; Pierre I Karakiewicz
Development and split-sample validation of a nomogram predicting the probability of seminal vesicle invasion at radical prostatectomy.
European urology 2007;52(1):98-105.
2007: Jose A Karam; Yair Lotan; Claus G Roehrborn; Raheela Ashfaq; Pierre I Karakiewicz; Shahrokh F Shariat
Caveolin-1 overexpression is associated with aggressive prostate cancer recurrence.
The Prostate 2007;67(6):614-22.
2007: Shahrokh F Shariat; Claus G Roehrborn; Pierre I Karakiewicz; Gurleen Dhami; Key H Stage
Evidence-based validation of the predictive value of the American Association for the Surgery of Trauma kidney injury scale.
The Journal of trauma 2007;62(4):933-9.
2007: Shahrokh F Shariat; Alexandre R Zlotta; Raheela Ashfaq; Arthur I Sagalowsky; Yair Lotan
Cooperative effect of cell-cycle regulators expression on bladder cancer development and biologic aggressiveness.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2007;20(4):445-59.
2007: Shahrokh F Shariat; Raheela Ashfaq; Pierre I Karakiewicz; Osamah Saeedi; Arthur I Sagalowsky; Yair Lotan
Survivin expression is associated with bladder cancer presence, stage, progression, and mortality.
Cancer 2007;109(6):1106-13.
2007: Vitaly Margulis; Shahrokh F Shariat; Raheela Ashfaq; Melissa Thompson; Arthur I Sagalowsky; Jer-Tsong Hsieh; Yair Lotan
Expression of cyclooxygenase-2 in normal urothelium, and superficial and advanced transitional cell carcinoma of bladder.
The Journal of urology 2007;177(3):1163-8.
2007: Matthew Nielsen; Shahrokh F Shariat; Pierre I Karakiewicz; Yair Lotan; Craig G Rogers; Gilad E Amiel; Patrick J Bastian; Amnon Vazina; Amit Gupta; Seth P Lerner; Arthur I Sagalowsky; Mark P Schoenberg; Ganesh S Palapattu
Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy.
European urology 2007;51(3):699-706; discussion 706-8.
2007: Jose A Karam; Yair Lotan; Pierre I Karakiewicz; Raheela Ashfaq; Arthur I Sagalowsky; Claus G Roehrborn; Shahrokh F Shariat
Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy.
The lancet oncology 2007;8(2):128-36.
2007: Shahrokh F Shariat; Claus G Roehrborn; John D McConnell; Sangtae Park; Nina Alam; Thomas M Wheeler; Kevin Slawin
Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(4):349-55.
2007: Shahrokh F Shariat; Raheela Ashfaq; Arthur I Sagalowsky; Yair Lotan
Predictive value of cell cycle biomarkers in nonmuscle invasive bladder transitional cell carcinoma.
The Journal of urology 2007;177(2):481-7; discussion 487.
2007: Shahrokh F Shariat
Selecting patients for immediate cystectomy.
Reviews in urology 2007;9(4):239-41.
2007: Shahrokh F Shariat; Ganesh S Palapattu; Pierre I Karakiewicz; Craig G Rogers; Amnon Vazina; Patrick J Bastian; Mark P Schoenberg; Seth P Lerner; Arthur I Sagalowsky; Yair Lotan
Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy.
European urology 2007;51(1):152-60.
2007: Shahrokh F Shariat; Ganesh S Palapattu; Pierre I Karakiewicz; Craig G Rogers; Amnon Vazina; Patrick J Bastian; Mark P Schoenberg; Seth P Lerner; Arthur I Sagalowsky; Yair Lotan
Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy.
European urology 2007;51(1):137-49; discussion 149-51.
2006: Vitaly Margulis; Shahrokh F Shariat; Raheela Ashfaq; Arthur I Sagalowsky; Yair Lotan
Ki-67 is an independent predictor of bladder cancer outcome in patients treated with radical cystectomy for organ-confined disease.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(24):7369-73.
2006: Shahrokh F Shariat; Pierre I Karakiewicz; Ganesh S Palapattu; Yair Lotan; Craig G Rogers; Gilad E Amiel; Amnon Vazina; Amit Gupta; Patrick J Bastian; Arthur I Sagalowsky; Mark P Schoenberg; Seth P Lerner
Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
The Journal of urology 2006;176(6 Pt 1):2414-22; discussion 2422.
2006: Shahrokh F Shariat; Raheela Ashfaq; Arthur I Sagalowsky; Yair Lotan
Correlation of cyclin D1 and E1 expression with bladder cancer presence, invasion, progression, and metastasis.
Human pathology 2006;37(12):1568-76.
2006: Pierre I Karakiewicz; Shahrokh F Shariat; Ganesh S Palapattu; Paul Perrotte; Yair Lotan; Craig G Rogers; Gilad E Amiel; Amnon Vazina; Amit Gupta; Patrick J Bastian; Arthur I Sagalowsky; Mark P Schoenberg; Seth P Lerner
Precystectomy nomogram for prediction of advanced bladder cancer stage.
European urology 2006;50(6):1254-60; discussion 1261-2.
2006: Shahrokh F Shariat; Pierre I Karakiewicz; Ganesh S Palapattu; Gilad E Amiel; Yair Lotan; Craig G Rogers; Amnon Vazina; Patrick J Bastian; Amit Gupta; Arthur I Sagalowsky; Mark P Schoenberg; Seth P Lerner
Nomograms provide improved accuracy for predicting survival after radical cystectomy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(22):6663-76.
2006: Pierre I Karakiewicz; Shahrokh F Shariat; Ganesh S Palapattu; Amiel E Gilad; Yair Lotan; Craig G Rogers; Amnon Vazina; Amit Gupta; Patrick J Bastian; Paul Perrotte; Arthur I Sagalowsky; Mark P Schoenberg; Seth P Lerner
Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder.
The Journal of urology 2006;176(4 Pt 1):1354-61; discussion 1361-2.
2006: Shahrokh F Shariat; Ganesh S Palapattu; Gilad E Amiel; Pierre I Karakiewicz; Craig G Rogers; Amnon Vazina; Mark P Schoenberg; Seth P Lerner; Arthur I Sagalowsky; Yair Lotan
Characteristics and outcomes of patients with carcinoma in situ only at radical cystectomy.
Urology 2006;68(3):538-42.
2006: Shahrokh F Shariat; Michael Marberger; Yair Lotan; Marta Sanchez-Carbayo; Craig D Zippe; Gerson Lüdecke; Hans Boman; Ihor S Sawczuk; Martin G Friedrich; Roberto Casella; Christine Mian; Sanaa Eissa; Hideyuki Akaza; Vincenzo Serretta; Hartwig Huland; Hans Hedelin; Rupesh Raina; Naoto Miyanaga; Arthur I Sagalowsky; Claus G Roehrborn; Pierre I Karakiewicz
Variability in the performance of nuclear matrix protein 22 for the detection of bladder cancer.
The Journal of urology 2006;176(3):919-26; discussion 926.
2006: Felix K-H Chun; Alberto Briganti; Shahrokh F Shariat; Markus Graefen; Francesco Montorsi; Andreas Erbersdobler; Thomas Steuber; Andrea Salonia; Eike Currlin; Vincenzo Scattoni; Martin G Friedrich; Thorsten Schlomm; Alexander Haese; Uwe Michl; Renzo Colombo; Hans Heinzer; Luc Valiquette; Patrizio Rigatti; Claus G Roehrborn; Hartwig Huland; Pierre I Karakiewicz
Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validation.
BJU international 2006;98(2):329-34.
2006: Lance P Walsh; Philippe E Zimmern; Norma Pope; Shahrokh F Shariat
Comparison of the Q-tip test and voiding cystourethrogram to assess urethral hypermobility among women enrolled in a randomized clinical trial of surgery for stress urinary incontinence.
The Journal of urology 2006;176(2):646-9; discussion 650.
2006: Craig G Rogers; Ganesh S Palapattu; Shahrokh F Shariat; Pierre I Karakiewicz; Patrick J Bastian; Yair Lotan; Amit Gupta; Amnon Vazina; Amiel Gilad; Arthur I Sagalowsky; Seth P Lerner; Mark P Schoenberg
Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder.
The Journal of urology 2006;175(6):2048-53; discussion 2053.
2006: Ganesh S Palapattu; Shahrokh F Shariat; Pierre I Karakiewicz; Patrick J Bastian; Craig G Rogers; Gilad E Amiel; Yair Lotan; Amnon Vazina; Amit Gupta; Arthur I Sagalowsky; Seth P Lerner; Mark P Schoenberg
Cancer specific outcomes in patients with pT0 disease following radical cystectomy.
The Journal of urology 2006;175(5):1645-9; discussion 1649.
2006: Pierre I Karakiewicz; Serge Benayoun; Craig D Zippe; Gerson Lüdecke; Hans Boman; Marta Sanchez-Carbayo; Roberto Casella; Christine Mian; Martin G Friedrich; Sanaa Eissa; Hideyuki Akaza; Hartwig Huland; Hans Hedelin; Raina Rupesh; Naoto Miyanaga; Arthur I Sagalowsky; Michael Marberger; Shahrokh F Shariat
Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder.
BJU international 2006;97(5):997-1001.
2006: Robert S Svatek; Michael P Herman; Yair Lotan; Roberto Casella; Jer-Tsong Hsieh; Arthur I Sagalowsky; Shahrokh F Shariat
Soluble Fas--a promising novel urinary marker for the detection of recurrent superficial bladder cancer.
Cancer 2006;106(8):1701-7.
2006: Shahrokh F Shariat; Khaled F Abdel-Aziz; Claus G Roehrborn; Yair Lotan
Pre-operative percent free PSA predicts clinical outcomes in patients treated with radical prostatectomy with total PSA levels below 10 ng/ml.
European urology 2006;49(2):293-302.
2005: Shahrokh F Shariat; David A Duchene; Wareef Kabbani; Zachary Mucher; Yair Lotan
Gastrointestinal hemorrhage as first manifestation of metastatic testicular tumor.
Urology 2005;66(6):1319.
2005: Shahrokh F Shariat; Raheela Ashfaq; Claus G Roehrborn; Kevin Slawin; Yair Lotan
Expression of survivin and apoptotic biomarkers in benign prostatic hyperplasia.
The Journal of urology 2005;174(5):2046-50.
2005: Shahrokh F Shariat; Grigorios Raptidis; Muramoto Masatoschi; Franco Bergamaschi; Kevin Slawin
Pilot study of radiofrequency interstitial tumor ablation (RITA) for the treatment of radio-recurrent prostate cancer.
The Prostate 2005;65(3):260-7.
2005: Yair Lotan; Amit Gupta; Shahrokh F Shariat; Ganesh S Palapattu; Amnon Vazina; Pierre I Karakiewicz; Patrick J Bastian; Craig G Rogers; Gilad E Amiel; Paul Perotte; Mark P Schoenberg; Seth P Lerner; Arthur I Sagalowsky
Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(27):6533-9.
2005: Shahrokh F Shariat; Michael P Herman; Roberto Casella; Yair Lotan; Jose A Karam; Ulf-Hakan Stenman
Urinary levels of tumor-associated trypsin inhibitor (TATI) in the detection of transitional cell carcinoma of the urinary bladder.
European urology 2005;48(3):424-31.
2005: Kazumasa Matsumoto; Shahrokh F Shariat; Gustavo E Ayala; Katherine A Rauen; Seth P Lerner
Loss of coxsackie and adenovirus receptor expression is associated with features of aggressive bladder cancer.
Urology 2005;66(2):441-6.
2005: Shahrokh F Shariat; Kazumasa Matsumoto; Roberto Casella; Weiguo Jian; Seth P Lerner
Urinary levels of soluble e-cadherin in the detection of transitional cell carcinoma of the urinary bladder.
European urology 2005;48(1):69-76.
2005: Shahrokh F Shariat; Craig D Zippe; Gerson Lüdecke; Hans Boman; Marta Sanchez-Carbayo; Roberto Casella; Christine Mian; Martin G Friedrich; Sanaa Eissa; Hideyuki Akaza; Ihor S Sawczuk; Vincenzo Serretta; Hartwig Huland; Hans Hedelin; Raina Rupesh; Naoto Miyanaga; Arthur I Sagalowsky; Frank H Wians; Claus G Roehrborn; Yair Lotan; Paul Perrotte; Serge Benayoun; Michael Marberger; Pierre I Karakiewicz
Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder.
The Journal of urology 2005;173(5):1518-25.
2005: Alvaro Ramirez; Paul Perrotte; Luc Valiquette; Francois Benard; Michael McCormack; Fred Saad; Caroline Fournier; Shahrokh F Shariat; Pierre I Karakiewicz
Exploration of health-related quality of life areas that may distinguish between continent diversion and ileal conduit patients.
The Canadian journal of urology 2005;12(1):2537-42.
2005: Kevin Slawin; Shahrokh F Shariat; Eduardo I Canto
BPSA: A Novel Serum Marker for Benign Prostatic Hyperplasia.
Reviews in urology 2005;7 Suppl 8():S52-6.
2005: Shahrokh F Shariat; Amir Alizadeh Naderi; Brian J Miles; Kevin Slawin
Anomalies of the wolffian duct derivatives encountered at radical prostatectomy.
Reviews in urology 2005;7(2):75-80.
2005: Pierre I Karakiewicz; Shahrokh F Shariat; Amir Naderi; Dov Kadmon; Kevin Slawin
Reliability of remembered International Index of Erectile Function domain scores in men with localized prostate cancer.
Urology 2005;65(1):131-5.
2004: Eduardo I Canto; Herb Singh; Shahrokh F Shariat; Dov Kadmon; Brian J Miles; Thomas M Wheeler; Kevin Slawin
Effects of systematic 12-core biopsy on the performance of percent free prostate specific antigen for prostate cancer detection.
The Journal of urology 2004;172(3):900-4.
2004: Seyed M Khoddami; Shahrokh F Shariat; Yair Lotan; Hossein Saboorian; John D McConnell; Arthur I Sagalowsky; Claus G Roehrborn; Kenneth S Koeneman
Predictive value of primary Gleason pattern 4 in patients with Gleason score 7 tumours treated with radical prostatectomy.
BJU international 2004;94(1):42-6.
2004: Shahrokh F Shariat; Andres Menesses-Diaz; Isaac Yi Kim; Masatoshi Muramoto; Thomas M Wheeler; Kevin Slawin
Tissue expression of transforming growth factor-beta1 and its receptors: correlation with pathologic features and biochemical progression in patients undergoing radical prostatectomy.
Urology 2004;63(6):1191-7.
2004: Herb Singh; Pierre I Karakiewicz; Shahrokh F Shariat; Eduardo I Canto; Rahul K Nath; Michael W Kattan; Kevin Slawin
Impact of unilateral interposition sural nerve grafting on recovery of urinary function after radical prostatectomy.
Urology 2004;63(6):1122-7.
2004: Eduardo I Canto; Shahrokh F Shariat; Kevin Slawin
Molecular diagnosis of prostate cancer.
Current urology reports 2004;5(3):203-11.
2004: Richard E Link; Shahrokh F Shariat; Cuong V Nguyen; Anita Farr; Armin D Weinberg; Ronald A Morton; Barbara Richardson; David Bernard; Kevin Slawin
Variation in prostate specific antigen results from 2 different assay platforms: clinical impact on 2304 patients undergoing prostate cancer screening.
The Journal of urology 2004;171(6 Pt 1):2234-8.
2004: Yair Lotan; Shahrokh F Shariat; Seyed M Khoddami; Hossein Saboorian; Kenneth S Koeneman; Jeffrey A Cadeddu; Arthur I Sagalowsky; John D McConnell; Claus G Roehrborn
The percent of biopsy cores positive for cancer is a predictor of advanced pathological stage and poor clinical outcomes in patients treated with radical prostatectomy.
The Journal of urology 2004;171(6 Pt 1):2209-14.
2004: Eduardo I Canto; Herb Singh; Shahrokh F Shariat; Dolores J Lamb; Stephen D Mikolajczyk; Harry J Linton; Harry G Rittenhouse; Dov Kadmon; Brian J Miles; Kevin Slawin
Serum BPSA outperforms both total PSA and free PSA as a predictor of prostatic enlargement in men without prostate cancer.
Urology 2004;63(5):905-10; discussion 910-1.
2004: Shahrokh F Shariat; Veronica A Anwuri; Dolores J Lamb; Nina V Shah; Thomas M Wheeler; Kevin Slawin
Association of preoperative plasma levels of vascular endothelial growth factor and soluble vascular cell adhesion molecule-1 with lymph node status and biochemical progression after radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(9):1655-63.
2004: Herb Singh; Eduardo I Canto; Shahrokh F Shariat; Dov Kadmon; Brian J Miles; Thomas M Wheeler; Kevin Slawin
Predictors of prostate cancer after initial negative systematic 12 core biopsy.
The Journal of urology 2004;171(5):1850-4.
2004: Makoto Ohori; Michael W Kattan; Hideshige Koh; Norio Maru; Kevin Slawin; Shahrokh F Shariat; Masatoshi Muramoto; Victor E Reuter; Thomas M Wheeler; Peter T Scardino
Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer.
The Journal of urology 2004;171(5):1844-9; discussion 1849.
2004: Amnon Vazina; Daniel D Dugi; Shahrokh F Shariat; Jeff Evans; Richard E Link; Seth P Lerner
Stage specific lymph node metastasis mapping in radical cystectomy specimens.
The Journal of urology 2004;171(5):1830-4.
2004: Andrew J Stephenson; Shahrokh F Shariat; Michael J Zelefsky; Michael W Kattan; E. Brian Butler; Bin S Teh; Eric A Klein; Patrick A Kupelian; Claus G Roehrborn; David A Pistenmaa; Heather D Pacholke; Stanley L Liauw; Matthew Katz; Steven A Leibel; Peter T Scardino; Kevin Slawin
Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy.
JAMA : the journal of the American Medical Association 2004;291(11):1325-32.
2004: Shahrokh F Shariat; Michael W Kattan; Erica Traxel; Ben Andrews; Kuichun Zhu; Thomas M Wheeler; Kevin Slawin
Association of pre- and postoperative plasma levels of transforming growth factor beta(1) and interleukin 6 and its soluble receptor with prostate cancer progression.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(6):1992-9.
2004: Shahrokh F Shariat; Hideo Tokunaga; JainHua Zhou; JaHong Kim; Gustavo E Ayala; William F Benedict; Seth P Lerner
p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(6):1014-24.
2004: Shahrokh F Shariat; Roberto Casella; Frank H Wians; Raheela Ashfaq; Jody Balko; Tullio Sulser; Thomas C Gasser; Arthur I Sagalowsky
Risk stratification for bladder tumor recurrence, stage and grade by urinary nuclear matrix protein 22 and cytology.
European urology 2004;45(3):304-13; author reply 313.
2004: Shahrokh F Shariat; Seyed M Khoddami; Hossein Saboorian; Kenneth S Koeneman; Arthur I Sagalowsky; Jeffrey A Cadeddu; John D McConnell; Marisa N Holmes; Claus G Roehrborn
Lymphovascular invasion is a pathological feature of biologically aggressive disease in patients treated with radical prostatectomy.
The Journal of urology 2004;171(3):1122-7.
2004: Herb Singh; Eduardo I Canto; Shahrokh F Shariat; Dov Kadmon; Brian J Miles; Thomas M Wheeler; Kevin Slawin
Improved detection of clinically significant, curable prostate cancer with systematic 12-core biopsy.
The Journal of urology 2004;171(3):1089-92.
2004: Shahrokh F Shariat; Yair Lotan; Hossein Saboorian; Seyed M Khoddami; Claus G Roehrborn; Kevin Slawin; Raheela Ashfaq
Survivin expression is associated with features of biologically aggressive prostate carcinoma.
Cancer 2004;100(4):751-7.
2004: Shahrokh F Shariat; Roberto Casella; Seyed M Khoddami; Gina Hernandez; Tullio Sulser; Thomas C Gasser; Seth P Lerner
Urine detection of survivin is a sensitive marker for the noninvasive diagnosis of bladder cancer.
The Journal of urology 2004;171(2 Pt 1):626-30.
2004: Shahrokh F Shariat; Eduardo I Canto; Michael W Kattan; Kevin Slawin
Beyond prostate-specific antigen: new serologic biomarkers for improved diagnosis and management of prostate cancer.
Reviews in urology 2004;6(2):58-72.
2004: Herb Singh; Eduardo I Canto; Shahrokh F Shariat; Dov Kadmon; Brian J Miles; Thomas M Wheeler; Kevin Slawin
Six additional systematic lateral cores enhance sextant biopsy prediction of pathological features at radical prostatectomy.
The Journal of urology 2004;171(1):204-9.
2003: Kazumasa Matsumoto; Shahrokh F Shariat; Roberto Casella; Thomas M Wheeler; Kevin Slawin; Seth P Lerner
Preoperative plasma soluble E-cadherin predicts metastases to lymph nodes and prognosis in patients undergoing radical cystectomy.
The Journal of urology 2003;170(6 Pt 1):2248-52.
2003: Shahrokh F Shariat; Roberto Casella; Mara A Monoski; Tullio Sulser; Thomas C Gasser; Seth P Lerner
The addition of urinary urokinase-type plasminogen activator to urinary nuclear matrix protein 22 and cytology improves the detection of bladder cancer.
The Journal of urology 2003;170(6 Pt 1):2244-7.
2003: Michael W Kattan; James A Eastham; Thomas M Wheeler; Norio Maru; Peter T Scardino; Andreas Erbersdobler; Markus Graefen; Hartwig Huland; Hideshige Koh; Shahrokh F Shariat; Kevin Slawin; Makoto Ohori
Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors.
The Journal of urology 2003;170(5):1792-7.
2003: Michael W Kattan; Shahrokh F Shariat; Ben Andrews; Kuichun Zhu; Eduardo I Canto; Kazumasa Matsumoto; Masatoshi Muramoto; Peter T Scardino; Makoto Ohori; Thomas M Wheeler; Kevin Slawin
The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(19):3573-9.
2003: Shahrokh F Shariat; Michael W Kattan; Weitao Song; David Bernard; Emanuel Gottenger; Thomas M Wheeler; Kevin Slawin
Early postoperative peripheral blood reverse transcription PCR assay for prostate-specific antigen is associated with prostate cancer progression in patients undergoing radical prostatectomy.
Cancer research 2003;63(18):5874-8.
2003: Shahrokh F Shariat; Kazumasa Matsumoto; JaHong Kim; Gustavo E Ayala; Jain-Hua Zhou; Weiguo Jian; William F Benedict; Seth P Lerner
Correlation of cyclooxygenase-2 expression with molecular markers, pathological features and clinical outcome of transitional cell carcinoma of the bladder.
The Journal of urology 2003;170(3):985-9.
2003: Shahrokh F Shariat; Martine P Roudier; George E Wilcox; Michael W Kattan; Peter T Scardino; Robert L Vessella; Sibel Erdamar; Cuong Nguyen; Thomas M Wheeler; Kevin Slawin
Comparison of immunohistochemistry with reverse transcription-PCR for the detection of micrometastatic prostate cancer in lymph nodes.
Cancer research 2003;63(15):4662-70.
2003: Shahrokh F Shariat; JaHong Kim; Grigorios Raptidis; Gustavo E Ayala; Seth P Lerner
Association of p53 and p21 expression with clinical outcome in patients with carcinoma in situ of the urinary bladder.
Urology 2003;61(6):1140-5.
2003: Shahrokh F Shariat; Mara A Monoski; Ben Andrews; Thomas M Wheeler; Seth P Lerner; Kevin Slawin
Association of plasma urokinase-type plasminogen activator and its receptor with clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder.
Urology 2003;61(5):1053-8.
2003: Eduardo I Canto; Shahrokh F Shariat; Kevin Slawin
Biochemical staging of prostate cancer.
The Urologic clinics of North America 2003;30(2):263-77.
2003: Shahrokh F Shariat; Michael W Kattan; Sibel Erdamar; Cuong Nguyen; Peter T Scardino; David M Spencer; Thomas M Wheeler; Kevin Slawin
Detection of clinically significant, occult prostate cancer metastases in lymph nodes using a splice variant-specific rt-PCR assay for human glandular kallikrein.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(7):1223-31.
2003: Shahrokh F Shariat; Ja-Hong Kim; Gustavo E Ayala; Kimberly Kho; Thomas M Wheeler; Seth P Lerner
Cyclooxygenase-2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder.
The Journal of urology 2003;169(3):938-42.
2003: Shahrokh F Shariat; JaHong Kim; Cuong Nguyen; Thomas M Wheeler; Seth P Lerner; Kevin Slawin
Correlation of preoperative levels of IGF-I and IGFBP-3 with pathologic parameters and clinical outcome in patients with bladder cancer.
Urology 2003;61(2):359-64.
2003: Shahrokh F Shariat; Kevin Slawin
Peripheral blood rt-PCR assays for detection and prognosis of prostate cancer.
Reviews in urology 2003;5(1):54-8.
2002: Roberto Casella; Shahrokh F Shariat; Mara A Monoski; Seth P Lerner
Urinary levels of urokinase-type plasminogen activator and its receptor in the detection of bladder carcinoma.
Cancer 2002;95(12):2494-9.
2002: Shahrokh F Shariat; Emanuel Gottenger; Cuong Nguyen; Weitao Song; Michael W Kattan; John Andenoro; Thomas M Wheeler; David M Spencer; Kevin Slawin
Preoperative blood reverse transcriptase-PCR assays for prostate-specific antigen and human glandular kallikrein for prediction of prostate cancer progression after radical prostatectomy.
Cancer research 2002;62(20):5974-9.
2002: Ben Andrews; Shahrokh F Shariat; Ja-Hong Kim; Thomas M Wheeler; Kevin Slawin; Seth P Lerner
Preoperative plasma levels of interleukin-6 and its soluble receptor predict disease recurrence and survival of patients with bladder cancer.
The Journal of urology 2002;167(3):1475-81.
2002: Shahrokh F Shariat; Dolores J Lamb; Michael W Kattan; Cuong Nguyen; JaHong Kim; Josie Beck; Thomas M Wheeler; Kevin Slawin
Association of preoperative plasma levels of insulin-like growth factor I and insulin-like growth factor binding proteins-2 and -3 with prostate cancer invasion, progression, and metastasis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(3):833-41.
2002: Alon Z Weizer; Shahrokh F Shariat; John L Haddad; Susan Escudier; Seth P Lerner
Metastatic transitional cell carcinoma of the urinary bladder to the shoulder girdle.
Reviews in urology 2002;4(2):97-9.
2002: Kevin Slawin; Eduardo I Canto; Shahrokh F Shariat; John L Gore; Edward Kim; Michael W Kattan; Thomas M Wheeler; Rahul K Nath
Sural Nerve Interposition Grafting during Radical Prostatectomy.
Reviews in urology 2002;4(1):17-23.
2001: Shahrokh F Shariat; J H Kim; Ben Andrews; Michael W Kattan; Thomas M Wheeler; Isaac Yi Kim; Seth P Lerner; Kevin Slawin
Preoperative plasma levels of transforming growth factor beta(1) strongly predict clinical outcome in patients with bladder carcinoma.
Cancer 2001;92(12):2985-92.
2001: Shahrokh F Shariat; Ben Andrews; Michael W Kattan; JaHong Kim; Thomas M Wheeler; Kevin Slawin
Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis.
Urology 2001;58(6):1008-15.
2001: J H Kim; Shahrokh F Shariat; Isaac Yi Kim; Andres Menesses-Diaz; Hideo Tokunaga; Thomas M Wheeler; Seth P Lerner
Predictive value of expression of transforming growth factor-beta(1) and its receptors in transitional cell carcinoma of the urinary bladder.
Cancer 2001;92(6):1475-83.
2001: Hideo Tokunaga; Shahrokh F Shariat; A E Green; R M Brown; J H Zhou; William F Benedict; Seth P Lerner
Correlation of immunohistochemical molecular staging of bladder biopsies and radical cystectomy specimens.
International journal of radiation oncology, biology, physics 2001;51(1):16-22.
2001: Shahrokh F Shariat; M Shalev; Andres Menesses-Diaz; Isaac Yi Kim; Michael W Kattan; Thomas M Wheeler; Kevin Slawin
Preoperative plasma levels of transforming growth factor beta(1) (TGF-beta(1)) strongly predict progression in patients undergoing radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(11):2856-64.
2001: J L Gore; Shahrokh F Shariat; Brian J Miles; Dov Kadmon; N Jiang; Thomas M Wheeler; Kevin Slawin
Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer.
The Journal of urology 2001;165(5):1554-9.
2001: R R Byrne; Shahrokh F Shariat; R Brown; Michael W Kattan; J R Morton RA; Thomas M Wheeler; Seth P Lerner
E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followup.
The Journal of urology 2001;165(5):1473-9.
2001: AK Leventis; Shahrokh F Shariat; Kevin Slawin
Local recurrence after radical prostatectomy: correlation of US features with prostatic fossa biopsy findings.
Radiology 2001;219(2):432-9.
2001: Shahrokh F Shariat; S Desai; Weitao Song; T Khan; J Zhao; Cuong Nguyen; Barbara A Foster; N Greenberg; David M Spencer; Kevin Slawin
Adenovirus-mediated transfer of inducible caspases: a novel "death switch" gene therapeutic approach to prostate cancer.
Cancer research 2001;61(6):2562-71.
2001: AK Leventis; Shahrokh F Shariat; T Utsunomiya; Kevin Slawin
Characteristics of normal prostate vascular anatomy as displayed by power Doppler.
The Prostate 2001;46(4):281-8.
2001: AK Leventis; Shahrokh F Shariat; Michael W Kattan; E B Butler; Thomas M Wheeler; Kevin Slawin
Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(4):1030-9.
2001: Shahrokh F Shariat; S Pahlavan; A G Baseman; R M Brown; A E Green; Thomas M Wheeler; Seth P Lerner
E-cadherin expression predicts clinical outcome in carcinoma in situ of the urinary bladder.
Urology 2001;57(1):60-5.
2000: Kevin Slawin; Shahrokh F Shariat; Cuong Nguyen; AK Leventis; Weitao Song; Michael W Kattan; C Y Young; D J Tindall; Thomas M Wheeler
Detection of metastatic prostate cancer using a splice variant-specific reverse transcriptase-polymerase chain reaction assay for human glandular kallikrein.
Cancer research 2000;60(24):7142-8.
2000: Shahrokh F Shariat; Alon Z Weizer; A Green; Rodolfo Laucirica; A Frolov; Thomas M Wheeler; Seth P Lerner
Prognostic value of P53 nuclear accumulation and histopathologic features in T1 transitional cell carcinoma of the urinary bladder.
Urology 2000;56(5):735-40.
2000: Shahrokh F Shariat; F Bergamaschi; H L Adler; Cuong Nguyen; Michael W Kattan; Thomas M Wheeler; Kevin Slawin
Correlation of preoperative plasma IGF-I levels with pathologic parameters and progression in patients undergoing radical prostatectomy.
Urology 2000;56(3):423-9.